{"study_id": 198427, "supplement_id": 1607, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the historical use, phytochemistry, pharmacology, and clinical applications of Commiphora mukul, including its combination with Terminalia Chebula.", "results_summary": "Terminalia Chebula was frequently combined with Commiphora mukul in traditional medicine formulations (101 times), suggesting its importance in treating conditions like rheumatoid arthritis, obesity, and hyperlipidemia, though specific efficacy data for Terminalia Chebula alone were not detailed.", "population_specificity": "Not specified (review of historical and modern literature across multiple traditional medicine systems).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:42.202314+00:00"}
{"study_id": 40420, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of testosterone replacement therapy (TRT) in managing heart failure (HF) by analyzing randomized controlled trials.", "results_summary": "TRT showed significant improvements in muscle strength, aerobic capacity, lean muscle mass, and insulin sensitivity, with no serious adverse effects reported. However, it did not consistently affect blood pressure, lipid profiles, or heart rate.", "population_specificity": "Human subjects aged 18 or older with a confirmed diagnosis of heart failure.", "effective_dosage": "Not specified", "study_duration": "At least 4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:43.258583+00:00"}
{"study_id": 40419, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether vitamin D status influences the cardiometabolic effects of testosterone replacement therapy in men with late-onset hypogonadism.", "results_summary": "Testosterone replacement therapy improved insulin sensitivity and reduced LDL cholesterol, uric acid, hsCRP, homocysteine, fibrinogen, and UACR in men with adequate vitamin D levels (groups II and III), but had limited effects in vitamin D-deficient men (group I). The therapy also reduced the Framingham Risk Score only in groups II and III.", "population_specificity": "Men with late-onset hypogonadism, stratified by vitamin D status (deficient, supplemented, or sufficient).", "effective_dosage": "250 mg intramuscular testosterone every three weeks.", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:43.758831+00:00"}
{"study_id": 40423, "supplement_id": 1608, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare rates of mortality, atrial fibrillation, stroke, myocardial infarction, and prostate cancer in hypogonadal men receiving TRT versus those who did not.", "results_summary": "TRT was associated with lower mortality (3.1% vs 3.6%), reduced atrial fibrillation (3.6% vs 4.0%), fewer strokes (1.6% vs 1.8%), and fewer prostate cancer cases (1.9% vs 2.9%) compared to no TRT.", "population_specificity": "Males aged 40 to 80 years diagnosed with hypogonadism.", "effective_dosage": "Not Assessed", "study_duration": "3-year outcomes analyzed.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:46.713504+00:00"}
{"study_id": 40422, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Testosterone Replacement Therapy (TRT) use within 90 days of reverse total shoulder arthroplasty (RSA) affects surgical outcomes such as revision rates, infections, or fractures.", "results_summary": "The study found no significant differences in revision RSA rates, periprosthetic joint infection (PJI) rates, or periprosthetic fracture rates between TRT users and non-users, suggesting TRT does not negatively impact RSA outcomes.", "population_specificity": "Patients undergoing reverse total shoulder arthroplasty (RSA) with at least 2 years of follow-up, including those receiving TRT for at least 90 days prior to surgery.", "effective_dosage": "Not specified", "study_duration": "At least 90 days prior to surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:46.767167+00:00"}
{"study_id": 40424, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to assess the risk of major cardiovascular events (MACE) and mortality in men with Klinefelter syndrome (KS) based on exposure to Testosterone Replacement Therapy (TRT).", "results_summary": "TRT was associated with lower all-cause mortality in men with KS, with mortality rates comparable to the background population. The incidence of MACE was similar between TRT-exposed and unexposed KS men, suggesting TRT is safe regarding cardiovascular risk.", "population_specificity": "Men with Klinefelter syndrome (KS).", "effective_dosage": "Not specified.", "study_duration": "Median follow-up time was 12.9 years (interquartile range; 7.5-20.7).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:47.106992+00:00"}
{"study_id": 40425, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the knowledge map of Testosterone Replacement Therapy (TRT) by analyzing trends, productivity, and research focus areas in published literature.", "results_summary": "The study found that TRT research has grown over time, with primary focus areas being hypogonadism, prostate cancer, and erectile dysfunction. Recent research has shifted towards topics like cardiovascular events, HIV, geriatric issues, and transgender health.", "population_specificity": "Global research output (primarily from the USA, UK, and Italy) without specific patient population details.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:49.383510+00:00"}
{"study_id": 40427, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to determine whether baseline testosterone levels or testosterone replacement therapy (TRT) affected the risk of COVID-19 and whether COVID-19 influenced the treatment response to TRT.", "results_summary": "The study found no significant difference in COVID-19 incidence, hospitalizations, or deaths between TRT and placebo groups. However, COVID-19 attenuated the treatment response to TRT in terms of hypogonadal symptoms, libido, energy, and hemoglobin/hematocrit changes.", "population_specificity": "Men aged 45 to 80 years with hypogonadism and cardiovascular disease or increased risk of cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:50.105321+00:00"}
{"study_id": 40430, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate testosterone levels in TRT donors and assess a mitigation strategy using pathogen reduction technology to potentially allow transfusion of plasma-based products from these donors.", "results_summary": "TRT donors had significantly higher free and total testosterone levels than controls. The CAD step in pathogen reduction effectively reduced supraphysiologic testosterone levels in plasma to within the reference range, while UVA light had no effect.", "population_specificity": "Male TRT donors and controls", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:51.460130+00:00"}
{"study_id": 40428, "supplement_id": 1608, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the latest knowledge on managing adverse effects of Testosterone Replacement Therapy (TRT), including gynecomastia, cardiovascular risks, prostate health, and liver dysfunction.", "results_summary": "TRT improves quality of life, sexual function, and mood in hypogonadal men but may cause adverse effects like gynecomastia and erythrocytosis, which require monitoring and management. No significant prostate cancer risk was found in closely monitored patients, but TRT is contraindicated in untreated prostate cancer cases.", "population_specificity": "Hypogonadal men", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:52.287197+00:00"}
{"study_id": 40433, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate the relationship between testosterone replacement therapy (TRT) and anterior cruciate ligament injury risk, as well as its potential benefits in postoperative recovery.", "results_summary": "The study suggests that supraphysiological testosterone supplementation may increase lean body mass postoperatively, potentially aiding recovery after anterior cruciate ligament surgery, but notes confounding variables and non-biological factors like increased motivation influencing outcomes.", "population_specificity": "Patients undergoing TRT, particularly those involved in sports or higher-risk activities.", "effective_dosage": "Not specified", "study_duration": "Short periods (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:56.874645+00:00"}
{"study_id": 40434, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the direct impact of testosterone therapy on the components of metabolic syndrome (excluding type 2 diabetes cases).", "results_summary": "Testosterone therapy led to significant improvements in waist circumference and triglycerides, supporting its potential therapeutic benefits for metabolic syndrome. However, long-term effects and safety require further research.", "population_specificity": "Male patients with metabolic syndrome, excluding those with type 2 diabetes as the sole diagnosis.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:56.876556+00:00"}
{"study_id": 40431, "supplement_id": 1608, "safety_score": "30", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether testosterone replacement therapy (TRT) could mitigate the risk of vertebral fractures.", "results_summary": "TRT was associated with a significantly higher 2-year incidence of vertebral fractures compared to non-TRT users, with rates increasing with age. Multivariate analysis identified TRT as a strong independent predictor of vertebral fractures, alongside chronic kidney disease, alcohol abuse, and diphosphonate use.", "population_specificity": "77,491 matched patients (74.3% male, mean age 54.7 \u00b1 10.4 years) with a mean Charlson Comorbidity Index of 0.17 \u00b1 0.54.", "effective_dosage": "Not Assessed", "study_duration": "2-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:57.143673+00:00"}
{"study_id": 40432, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the dose-response relationship of testosterone replacement therapy (TRT) combined with exercise on muscle hypertrophy and fat loss in a trained male over an eight-month period.", "results_summary": "TRT combined with regular exercise significantly increased lean muscle mass (6% in Phase 1, 3.8% in Phase 2) and reduced body fat (1.7% in Phase 1, 1.3% in Phase 2), while improving basal metabolic rate. Exercise intensity shifted over time, with increased moderate-to-high-intensity activity in Phase 1 and more low-intensity activity in Phase 2, suggesting cardiovascular adaptation.", "population_specificity": "40-year-old trained male with 25 years of consistent exercise experience.", "effective_dosage": "150 mg per week for the first three weeks, then 180 mg per week thereafter, self-administered three times per week.", "study_duration": "Eight months (two months pre-TRT, three months Phase 1 TRT, three months Phase 2 TRT).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:58.228679+00:00"}
{"study_id": 40437, "supplement_id": 1608, "safety_score": "60", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to validate the secondary findings of the TRAVERSE trial regarding the risks of new-onset atrial fibrillation (AF) and acute kidney injury (AKI) in hypogonadal men receiving testosterone replacement therapy (TRT).", "results_summary": "The study found that TRT was associated with a significantly increased risk of AKI but not with a significantly increased risk of new-onset AF. The results align with the TRAVERSE trial's secondary findings.", "population_specificity": "Hypogonadal men aged 45-80 years with testosterone levels of 100-300 ng/dL.", "effective_dosage": "Not specified (topical testosterone therapy).", "study_duration": "Outcomes assessed within 3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:00.745614+00:00"}
{"study_id": 40436, "supplement_id": 1608, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of testosterone treatment (TT) in modulating the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) by assessing its effects on liver steatosis and fibrosis.", "results_summary": "The study found that TT reduced liver steatosis and, in some cases, led to resolution of MASLD and regression of liver fibrosis. Adverse events were comparable between TT and control groups, and liver enzyme levels decreased with TT.", "population_specificity": "Men with MASLD and low testosterone.", "effective_dosage": "Varying doses, routes, and frequencies (not specified in detail).", "study_duration": "Follow-up ranged from 12 weeks to 8 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:02.759678+00:00"}
{"study_id": 40443, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association between testosterone replacement therapy (TRT) and carotid artery atherosclerosis, including its effects on lipid profiles and inflammatory markers.", "results_summary": "The meta-analysis found no association between TRT and carotid artery atherosclerosis or other assessed markers (HDL, LDL, CRP, total cholesterol). TRT significantly increased total testosterone levels, suggesting potential indirect anti-atherosclerotic effects.", "population_specificity": "Hypogonadal males receiving exogenous testosterone.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:05.629396+00:00"}
{"study_id": 40440, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the effects of testosterone replacement therapy on various physiological systems, including bones, cardiac function, sexuality, and potential concerns like prostate carcinoma.", "results_summary": "The abstract highlights the broad effects of testosterone replacement therapy but does not specify quantitative outcomes. It mentions areas of concern, such as prostate carcinoma, alongside benefits for bones, cardiac function, and sexuality.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:05.699711+00:00"}
{"study_id": 40442, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety, clinical and cost-effectiveness of testosterone replacement therapy for men with hypogonadism, as well as assess men's experiences with the treatment.", "results_summary": "The study found no significant difference in cardiovascular or cerebrovascular events between testosterone replacement therapy and placebo groups. Testosterone therapy improved quality of life and sexual function without adverse effects on blood pressure, lipids, or glycaemic markers.", "population_specificity": "Men with male hypogonadism.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:06.047513+00:00"}
{"study_id": 40438, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of testosterone replacement therapy (TRT) on the Fibrosis-4 (FIB-4) index in hypogonadal patients.", "results_summary": "TRT significantly improved the FIB-4 index in hypogonadal men with a higher baseline FIB-4 index, alongside reductions in waist circumference, body fat volume, and triglyceride levels, and an increase in platelet counts. No significant change in the FIB-4 index was observed in the overall study population.", "population_specificity": "Hypogonadal patients from Japan (186 participants: 88 in TRT group, 98 in control group).", "effective_dosage": "250 mg testosterone enanthate intramuscularly every 4 weeks.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:06.097072+00:00"}
{"study_id": 40445, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether low serum testosterone levels were associated with an increased risk of developing an initial kidney stone diagnosis in adult men.", "results_summary": "The study found that low testosterone (<300 ng/dL) was associated with a higher risk of kidney stone diagnoses in men aged \u226518, particularly in those aged 34-44 (HR 1.29). No significant association was observed in men aged 18-24.", "population_specificity": "Men aged \u226518 without a history of kidney stones or testosterone therapy prescriptions.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:08.534359+00:00"}
{"study_id": 40444, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the independent and joint effects of pre-diagnostic use of statins and testosterone replacement therapy (TTh) on the risk of hormone-related cancers (HRCs), including prostate, colorectal, and male breast cancers.", "results_summary": "The study found inverse joint associations of statins and TTh with reduced risks of HRCs, including prostate, aggressive prostate, and colorectal cancers, particularly within the first three years of follow-up. The greatest risk reduction was observed among dual users (statins plus TTh), with similar patterns in White and Black men.", "population_specificity": "105,690 men aged 65+ (82,578 White and 10,256 Black men) from the SEER-Medicare 2007-2015 dataset.", "effective_dosage": "Not specified", "study_duration": "Follow-up period included assessments before and after 3 years.", "interactions": "Statins (dual use with TTh showed enhanced effects)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:09.143552+00:00"}
{"study_id": 40446, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To determine how changes in testosterone, dihydrotestosterone, and estradiol concentrations during testosterone replacement therapy affect the free testosterone fraction in men with hypogonadism.", "results_summary": "Testosterone replacement therapy increased total testosterone, dihydrotestosterone, estradiol, and free testosterone concentrations, as well as the percent free testosterone. Changes in estradiol had a disproportionately larger effect on free testosterone fraction compared to testosterone and dihydrotestosterone.", "population_specificity": "Men with hypogonadism", "effective_dosage": "Not available", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:10.612096+00:00"}
{"study_id": 40429, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to examine the impact of testosterone replacement therapy (TRT) on PSA levels and prostate biopsy progression in men with low testosterone undergoing active surveillance for prostate cancer.", "results_summary": "TRT significantly increased testosterone levels but did not significantly alter PSA levels. Biopsy data showed no apparent increase in prostate cancer progression, with 80% of patients showing no disease progression over a mean of 44.3 months.", "population_specificity": "Men with low testosterone undergoing active surveillance for prostate cancer.", "effective_dosage": "Not specified", "study_duration": "Mean follow-up of 44.3 months (range up to 79.5 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:10.999291+00:00"}
{"study_id": 40448, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to provide primary care NPs with a comprehensive understanding of TRT for managing hypogonadism, based on current guidelines.", "results_summary": "The abstract does not report specific findings on TRT's effects but serves as a primer for evidence-based care, covering etiology, clinical presentation, diagnostic criteria, and treatment options.", "population_specificity": "Men diagnosed with hypogonadism.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:13.305707+00:00"}
{"study_id": 40449, "supplement_id": 1608, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to highlight potential risks of synchronous prostate and male breast cancer recurrence following testosterone replacement therapy (TRT) in a patient with a history of prostate cancer.", "results_summary": "The study reported a case of recurrent metastatic prostate cancer and new male breast cancer in a patient self-administering TRT, suggesting potential risks of TRT in patients with a history of these malignancies.", "population_specificity": "A 72-year-old man with previously treated intermediate-risk prostate adenocarcinoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:13.639472+00:00"}
{"study_id": 40453, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the phenotypic and functional profiles of platelets from donors on testosterone replacement therapy (TRT) versus control donors to assess their suitability for transfusion.", "results_summary": "TRT donor platelets showed no significant differences from control donor platelets in count, surface phenotype, metabolic function, aggregation, thrombin generation, or thrombus formation. Both groups exhibited similar declines in hemostatic function by Day 7 of storage.", "population_specificity": "Age- and sex-matched donors (N=10 per group) undergoing TRT or serving as controls.", "effective_dosage": "Not specified", "study_duration": "Platelets were stored and analyzed over 7 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:14.994834+00:00"}
{"study_id": 40455, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "To assess the effectiveness of testosterone replacement therapy (TRT) for managing cachexia in patients with chronic diseases such as cancer, COPD, HIV/AIDS, and liver cirrhosis.", "results_summary": "TRT showed mixed results favoring clinical improvement in lean body mass, energy levels, and quality of life across the studied chronic diseases, though data variability suggests the need for further long-term studies.", "population_specificity": "Patients with chronic diseases (cancer, COPD, HIV/AIDS, liver cirrhosis) and associated cachexia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:17.136336+00:00"}
{"study_id": 40454, "supplement_id": 1608, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and clinical implications of testosterone replacement therapy for men with testosterone deficiency, focusing on symptom improvement and cardiovascular risk.", "results_summary": "Testosterone replacement therapy improved sexual function, depressive symptoms, bone density, and lean body mass, with conflicting evidence on cardiovascular risk. A large randomized trial found no increased risk of myocardial infarction or stroke, even in high-risk patients.", "population_specificity": "Men with testosterone deficiency (male hypogonadism).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Potential for medication interactions mentioned, but no specifics provided.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:17.229339+00:00"}
{"study_id": 40451, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of different testosterone replacement therapy (TRT) administration routes on lower urinary tract symptoms (LUTS) in aging men with late-onset hypogonadism (LOH).", "results_summary": "The study found no significant differences in IPSS, PSA levels, or prostate volume between TRT routes, but intramuscular TRT showed potential as the preferred method for reducing IPSS. Long-term intramuscular TRT significantly decreased IPSS, while short-term transdermal TRT increased PSA levels and short-term intramuscular TRT increased prostate volume.", "population_specificity": "Aging men with late-onset hypogonadism (LOH) and lower urinary tract symptoms (LUTS).", "effective_dosage": "Not specified", "study_duration": "Varied (short-term and long-term subgroups analyzed)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:17.339111+00:00"}
{"study_id": 40457, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Testosterone Replacement Therapy (TRT) in prostate cancer patients and identify the optimal population for TRT post-treatment.", "results_summary": "TRT improved erectile function and reduced cardiovascular morbidity in men without prostate cancer history, leading to better overall survival. However, its safety and efficacy in prostate cancer patients remain uncertain.", "population_specificity": "Men with no history of prostate cancer and prostate cancer patients post-treatment.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:19.296010+00:00"}
{"study_id": 40456, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether testosterone replacement therapy (TRT) increases the risk of adverse prostate events in men with hypogonadism who were screened to exclude high-risk prostate cancer cases.", "results_summary": "The study found that TRT did not increase the incidence of high-grade or any prostate cancer, acute urinary retention, surgical procedures for benign prostatic hyperplasia, prostate biopsies, or new pharmacologic therapy for lower urinary tract symptoms compared to placebo. TRT was associated with a greater increase in prostate-specific antigen (PSA) in the first year but did not worsen lower urinary tract symptoms.", "population_specificity": "Men with hypogonadism, carefully screened to exclude those at high risk of prostate cancer.", "effective_dosage": "Not specified", "study_duration": "1 year or longer", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:20.265211+00:00"}
{"study_id": 40461, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the cardiovascular safety of testosterone replacement therapy (TRT) in men with hypogonadism by analyzing recent randomized controlled trials.", "results_summary": "The study found no significant increase in cardiovascular disease events, stroke, myocardial infarction, all-cause mortality, or CVD mortality between TRT and placebo groups. The results suggest TRT does not elevate CVD risk or mortality in hypogonadal men.", "population_specificity": "Men with hypogonadism (mean age 61.61-61.82 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:22.297876+00:00"}
{"study_id": 40458, "supplement_id": 1608, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the relationship between testosterone replacement therapy (TRT) and tenosynovitis of the hand, specifically trigger finger and de Quervain tenosynovitis.", "results_summary": "TRT was associated with more than twice the likelihood of developing trigger finger and an increased risk of de Quervain tenosynovitis. Patients on TRT were also roughly twice as likely to require steroid injections or surgical release for these conditions compared to controls.", "population_specificity": "Adult patients who filled a prescription for TRT for 3 consecutive months between 2010 and 2019.", "effective_dosage": "Not specified", "study_duration": "3 consecutive months (minimum)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:22.791949+00:00"}
{"study_id": 40462, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to systematically review and meta-analyze the cardiovascular risk related to testosterone replacement therapy (TRT) using placebo-controlled randomized trials and population-based studies.", "results_summary": "The study found no significant difference in major adverse cardiovascular events between TRT and placebo. While one trial reported an increased incidence of non-fatal arrhythmias and atrial fibrillation (AF), this was not confirmed in other studies, and no relationship was found between endogenous testosterone levels and AF incidence after adjusting for confounders.", "population_specificity": "8,126 subjects treated with TRT and 7,310 patients allocated to placebo across 106 studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:24.174461+00:00"}
{"study_id": 40465, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of testosterone undecanoate (TU) on blood pressure in men with adult-onset testosterone deficiency, addressing concerns raised in product warnings.", "results_summary": "TU was associated with significant reductions in systolic, diastolic BP, and pulse pressure, particularly in men with higher baseline BP. Few men required new antihypertensive therapy, and some discontinued existing antihypertensive medications during follow-up.", "population_specificity": "737 men with adult-onset testosterone deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Antihypertensive therapy (concurrent use or discontinuation noted)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:26.296384+00:00"}
{"study_id": 40464, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to determine the effects of testosterone replacement therapy (TRT) on hypogonadism-related symptoms and overall quality of life in a post-COVID-19 patient with hypogonadotropic hypogonadism.", "results_summary": "TRT improved serum testosterone levels and hypogonadism-related symptoms but had minimal effects on general and neuropsychiatric symptoms and quality of life, suggesting these issues may be linked to long-COVID rather than hypogonadism.", "population_specificity": "A 62-year-old man with hypogonadotropic hypogonadism following COVID-19 recovery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:26.317831+00:00"}
{"study_id": 40466, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to determine if testosterone therapy affects post-operative surgical scarring in transgender patients undergoing mastectomy.", "results_summary": "The study found no statistically significant difference in scar quality between testosterone-treated and non-treated groups, suggesting testosterone therapy does not significantly impact surgical scarring.", "population_specificity": "Transgender patients who underwent mastectomy as gender-affirming surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:26.763844+00:00"}
{"study_id": 40467, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the independent and joint effects of pre-diagnostic use of statins and testosterone replacement therapy on mortality risk in older men diagnosed with hormone-related cancers.", "results_summary": "Testosterone replacement therapy alone was associated with a 24% lower risk of all-cause death and a 57% lower risk of prostate cancer-specific death in aggressive prostate cancer cases. No significant associations were found for colorectal or male breast cancer.", "population_specificity": "Older men (\u226565 years) diagnosed with hormone-related cancers (prostate, colorectal, and male breast cancer).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:29.394163+00:00"}
{"study_id": 40469, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize new methods for optimizing fertility in hypogonadal patients undergoing testosterone replacement therapy and provide guidance for healthcare providers.", "results_summary": "The study highlights that traditional testosterone replacement therapy can suppress fertility via the HPG axis but notes recent advances in administration methods and ancillary medications may mitigate this effect.", "population_specificity": "Hypogonadal men", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:30.527587+00:00"}
{"study_id": 40468, "supplement_id": 1608, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review current literature on Testosterone Replacement Therapy (TRT) and its relationship with orthopaedic conditions, surgical outcomes, and potential benefits or risks in orthopaedic patients.", "results_summary": "The study highlights TRT's potential benefits in postoperative rehabilitation, osseous healing, and bone-implant integration, but also notes concerns about adverse risks such as venous thromboembolic complications, cardiovascular events, and prostate issues. The authors suggest further research to optimize TRT's benefits while mitigating risks in orthopaedic patients.", "population_specificity": "Orthopaedic patients, including those with late-onset hypogonadism, congenital syndromes, or undergoing gender affirmation hormonal therapy.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:31.452976+00:00"}
{"study_id": 40470, "supplement_id": 1608, "safety_score": "40", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to assess associations between testosterone replacement therapy (TRT) and endocrine, cardiovascular, and psychosocial late effects in male childhood cancer survivors.", "results_summary": "The study found that men on TRT had a higher prevalence of endocrine deficiencies, cholesterol medication use, depressive symptoms, fatigue, and lower rates of living with a partner, having biological children, or current occupation. TRT was associated with hematopoietic stem cell transplantation and cranial radiotherapy.", "population_specificity": "Male childhood cancer survivors aged 19-40 years in Sweden, diagnosed between 1981-2017.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:33.244747+00:00"}
{"study_id": 40471, "supplement_id": 1608, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effectiveness and safety of Testosterone Replacement Therapy (TRT) for treating aging-related late-onset hypogonadism (LOH).", "results_summary": "TRT significantly improved erectile function (IIEF score) without negatively affecting prostate-related outcomes (IPSS, PV, Qmax, PVR, PSA). The results were consistent across different administration methods and treatment durations.", "population_specificity": "Hypogonadal men with late-onset hypogonadism (LOH).", "effective_dosage": "Not specified (various modalities: injection, oral, transdermal).", "study_duration": "Varied (11 long-term studies \u226512 months, 18 short-term studies <12 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:35.820928+00:00"}
{"study_id": 40473, "supplement_id": 1608, "safety_score": "65", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the clinical benefits and risks of Testosterone Replacement Therapy (TRT) in populations such as those with hypogonadism, based on literature from the last decade.", "results_summary": "The study found that TRT improves libido, muscle mass, cognition, and quality of life but is associated with side effects like polycythemia, BPH, prostate cancer, gynecomastia, testicular atrophy, and infertility. The authors concluded that the benefits outweigh the risks, leading to improved quality of life and symptom remission in hypogonadism.", "population_specificity": "Individuals with hypogonadism, including symptomatic age-related hypogonadism.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:35.957620+00:00"}
{"study_id": 40474, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of testosterone-replacement therapy (TRT) on depressive symptoms, energy, sleep quality, and cognition in hypogonadal men with and without depressive symptoms.", "results_summary": "TRT was associated with modest but significant improvements in mood and energy in hypogonadal men with and without significant depressive symptoms, but no significant effects on cognition or sleep quality. No significant differences were observed in men with rigorously defined low-grade persistent depressive disorder (LG-PDD), possibly due to low statistical power.", "population_specificity": "Men aged 45 to 80 years with hypogonadism (2 fasting testosterone levels <300 ng/dL), 1 or more hypogonadal symptoms, and cardiovascular disease (CVD) or increased CVD risk.", "effective_dosage": "1.62% transdermal testosterone gel (specific frequency not mentioned).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:38.007395+00:00"}
{"study_id": 40475, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the relationship between hypogonadism, testosterone replacement therapy (TRT), and the risk of developing localized and metastatic prostate cancer in hypogonadal men.", "results_summary": "The study found that both untreated hypogonadism and TRT in hypogonadal men were associated with significantly decreased risks of localized and metastatic prostate cancer compared to eugonadal controls, with TRT showing slightly better outcomes for localized cancer.", "population_specificity": "Hypogonadal men and matched eugonadal controls from the Merative MarketScan database (total n=3,222,904).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:38.257645+00:00"}
{"study_id": 40463, "supplement_id": 1608, "safety_score": "65", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combination therapy with SGLT-2 inhibitors and Testosterone Replacement Therapy (TRT) increases the risk of erythrocytosis compared to either treatment alone in patients with type 2 diabetes.", "results_summary": "The study found that combined SGLT-2i and TRT therapy significantly increased the odds of erythrocytosis compared to either treatment alone, with adjusted odds ratios of 3.80 (vs. SGLT-2i alone) and 2.49 (vs. TRT alone). Testosterone delivery route (topical vs. injectable) did not affect the increased risk.", "population_specificity": "US Veterans with type 2 diabetes and baseline hematocrit between 38 and 50%.", "effective_dosage": "Not specified", "study_duration": "Follow-up within 365 days of therapy initiation", "interactions": "Interaction with SGLT-2 inhibitors noted, increasing erythrocytosis risk.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:38.890729+00:00"}
{"study_id": 40477, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the association between testosterone therapy (TTh) and mortality in men with adult-onset testosterone deficiency, particularly focusing on cardio-metabolic risk factors.", "results_summary": "The study found that testosterone undecanoate (TU) was associated with significantly lower mortality (hazard ratio = 0.23), especially in men with higher cardio-metabolic risk. The association remained independent of baseline age and other risk factors.", "population_specificity": "737 men with adult-onset testosterone deficiency (serum total testosterone \u226412.1 nmol/L and associated symptoms).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 114 months (IQR 84-132 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:40.565826+00:00"}
{"study_id": 40476, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of testosterone replacement therapy (TRT) versus placebo on prostate-related outcomes, including high-grade prostate cancer, acute urinary retention, and other adverse prostate events in men with hypogonadism.", "results_summary": "The study found no significant differences in the incidences of high-grade prostate cancer, any prostate cancer, acute urinary retention, invasive prostate procedures, or pharmacologic treatment between TRT and placebo groups. PSA concentrations increased more in the TRT group, but no significant adverse prostate events were observed.", "population_specificity": "Middle-aged and older men (aged 45-80 years) with hypogonadism, low testosterone concentrations (<300 ng/dL), and cardiovascular disease or increased cardiovascular risk, excluding those with high prostate-specific antigen (PSA > 3.0 ng/mL) or severe urinary symptoms (IPSS > 19).", "effective_dosage": "Topical 1.62% testosterone gel (specific frequency not mentioned).", "study_duration": "Mean treatment duration was approximately 21.8 months in the TRT group and 21.6 months in the placebo group.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:43.028356+00:00"}
{"study_id": 40478, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether testosterone replacement therapy (TRT) increases the risk of prostate cancer (PCa) incidence, aggressiveness, or mortality, as well as cardiovascular disease (CVD) mortality, compared to non-users.", "results_summary": "TRT users showed no increased risk of PCa incidence or mortality and had lower PCa mortality (HR = 0.52) compared to non-users. Additionally, TRT users had slightly lower CVD and all-cause mortality, with no time- or dose-dependency observed.", "population_specificity": "78,615 Finnish men aged 55\u201367 years with or without late-onset hypogonadism (LOH).", "effective_dosage": "Not specified", "study_duration": "Follow-up over 18 years (1995\u20132015)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:43.805341+00:00"}
{"study_id": 40479, "supplement_id": 1608, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "To assess the effects of 18 months of testosterone replacement therapy (TRT) on hemostasis in men with Klinefelter syndrome (KS) and identify genes associated with the prothrombotic phenotype.", "results_summary": "TRT in KS was associated with reduced body fat and fibrinogen, attenuating the prothrombotic profile. KS was linked to fibrinolytic impairment, which TRT helped mitigate, though thrombin generation was slightly increased in untreated KS.", "population_specificity": "Men with Klinefelter syndrome (KS) and healthy controls.", "effective_dosage": "Not specified", "study_duration": "18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:44.111834+00:00"}
{"study_id": 40480, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the independent and combined associations of statins and testosterone replacement therapy (TTh) with incident cardiovascular disease (CVD) in hormone-related cancer survivors and a matched cancer-free cohort.", "results_summary": "The study found that TTh was independently inversely associated with incident CVD in the overall sample (OR = 0.81) and in combination with statins (OR = 0.60). However, among hormone-related cancer survivors, only the combination of TTh plus statins showed an inverse association with CVD, while TTh alone was not associated.", "population_specificity": "44,330 men (22,165 hormone-related cancer survivors and 22,165 age-and index-matched cancer-free individuals) from SEER-Medicare 2007-2015.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "Statins", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:46.415265+00:00"}
{"study_id": 40481, "supplement_id": 1608, "safety_score": "65", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the associative relationship between consistent testosterone replacement therapy (TRT) and the risk of Achilles tendon injury and subsequent surgery.", "results_summary": "The study found a significant association between TRT and increased incidence of Achilles tendon injury (377.8 vs. 245.8 per 100,000 person-years) and a higher likelihood of surgical intervention (9.0% vs. 6.4%) compared to controls.", "population_specificity": "Patients aged 35-75 who were prescribed at least 3 consecutive months of TRT between 2010 and 2019.", "effective_dosage": "Not specified", "study_duration": "Minimum of 3 consecutive months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:47.454186+00:00"}
{"study_id": 40483, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the relationship between testosterone replacement therapy (TRT) and the risk of arterial/venous thrombosis and mortality in men with pre-treatment total testosterone <12 nmol/L.", "results_summary": "Based on RCT data, TRT did not significantly influence the risk of arterial thrombosis, stroke, MI, VTE, pulmonary embolism, or mortality. Observational studies suggested a reduction in arterial thrombotic events, MI, VTE, and mortality, though DVT risk remains uncertain due to limited RCT data.", "population_specificity": "Men with total testosterone <12 nmol/L or clear hypogonadism.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:47.820225+00:00"}
{"study_id": 40484, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess whether testosterone replacement therapy (TRT) could correct anemia in men with hypogonadism and anemia, and reduce the risk of developing anemia in those without anemia.", "results_summary": "TRT was significantly more effective than placebo in correcting anemia in men with hypogonadism and anemia, and a smaller proportion of testosterone-treated men without anemia developed anemia compared to placebo-treated men. Changes in hemoglobin were associated with changes in energy levels.", "population_specificity": "Middle-aged and older men (aged 45-80 years) with hypogonadism, cardiovascular disease, or increased cardiovascular risk.", "effective_dosage": "1.62% testosterone gel daily", "study_duration": "Up to 48 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:48.141096+00:00"}
{"study_id": 40485, "supplement_id": 1608, "safety_score": "30", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the association between obstructive sleep apnoea syndrome (OSAS), male hypogonadism (MH), and testosterone replacement therapy (TRT), including the potential risks and benefits of TRT in hypogonadal men with OSAS.", "results_summary": "The study found that TRT is generally contraindicated in untreated or severe OSAS due to potential worsening of symptoms and exacerbation of polycythaemia. However, long-term lower doses of TRT might improve OSAS symptoms, while short-term high doses could worsen them.", "population_specificity": "Hypogonadal men affected by untreated or severe obstructive sleep apnoea syndrome (OSAS).", "effective_dosage": "Not specified (mentions short-term high-dose vs. long-term lower doses).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:50.516482+00:00"}
{"study_id": 40489, "supplement_id": 1608, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether testosterone replacement therapy posed increased cardiovascular risks compared to a placebo in men with or at high risk for cardiovascular disease.", "results_summary": "The study found that testosterone replacement therapy was no worse than a placebo in terms of cardiovascular risks for men with or at high risk for cardiovascular disease, suggesting it may be a viable treatment for hypogonadal men.", "population_specificity": "Men with cardiovascular disease or at high risk for cardiovascular disease.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:52.241399+00:00"}
{"study_id": 40488, "supplement_id": 1608, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to systematically evaluate the effect of testosterone replacement therapy (TRT) on metabolic indexes in patients with hypogonadism.", "results_summary": "TRT improved metabolic indexes by reducing fasting plasma glucose, fasting insulin, total cholesterol, and waist circumference, but increased systolic and diastolic blood pressure. No significant improvements were observed in glycosylated hemoglobin or triglyceride levels.", "population_specificity": "Patients with hypogonadism (1,553 cases across 19 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:52.244043+00:00"}
{"study_id": 40487, "supplement_id": 1608, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "To update the 2015 EMAS statement on Testosterone Replacement Therapy (TRT) in older men with new research on late-onset hypogonadism and TRT.", "results_summary": "TRT may improve sexual function, insulin resistance, and quality of life in symptomatic older men with confirmed low testosterone, but long-term safety remains uncertain. It is contraindicated in certain conditions like active prostate cancer, recent cardiovascular events, and severe heart failure.", "population_specificity": "Older men with late-onset hypogonadism (symptomatic low testosterone without organic disease).", "effective_dosage": "Not specified (short-acting transdermal preparations preferred initially, injectable forms may follow).", "study_duration": "Not specified (monitoring recommended at 3, 6, and 12 months, then yearly).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:53.298932+00:00"}
{"study_id": 40491, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "To investigate the impact of testosterone replacement therapy (TRT) on cardiovascular outcomes in hypogonadal men.", "results_summary": "The study found no statistically significant differences in cardiovascular outcomes, including mortality and adverse events, between the TRT group and the control group. Sensitivity and meta-regression analyses supported the robustness of these findings.", "population_specificity": "Hypogonadal men (10,941 participants across 26 randomized controlled trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:53.550878+00:00"}
{"study_id": 40496, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to analyze the link between testosterone replacement therapy (TRT) and adverse cardiovascular (CV) events.", "results_summary": "The study found that while some flawed studies suggested a link between TRT and CV events, many others showed TRT reduced CV events, improved CVD risk factors, and had cardioprotective effects in hypogonadal men.", "population_specificity": "Hypogonadal men, particularly those with cardiovascular disease (CVD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:55.398264+00:00"}
{"study_id": 40497, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of testosterone versus placebo treatment on NAFLD scores and liver scans in elderly hypogonadal men.", "results_summary": "The study found no statistically significant differences in NAFLD scores or liver CT measures between testosterone and placebo groups after 12 months of treatment, indicating no improvement in NAFLD with testosterone therapy.", "population_specificity": "Older hypogonadal men with total testosterone < 275 ng/dL (n=479).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:55.756216+00:00"}
{"study_id": 40498, "supplement_id": 1608, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the criteria, management, and safety considerations of Testosterone Replacement Therapy (TRT) for men with hypogonadism.", "results_summary": "The study found that TRT is effective for men with hypogonadism when criteria are met, but its use is limited by contraindications, adverse effects, and insufficient long-term safety data. Multiple formulations are available, with choice depending on cost and patient preference, and nonhormonal alternatives exist for those unsuitable for TRT.", "population_specificity": "Men with hypogonadism (low testosterone levels and associated symptoms).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:57.781869+00:00"}
{"study_id": 40501, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate patient preferences for Testosterone Replacement Therapy (TRT) and factors associated with increased treatment satisfaction.", "results_summary": "62.7% of patients were satisfied with their TRT regimen, with higher satisfaction rates for auto-injectors (91.7%), subcutaneous pellets (90.0%), and intramuscular injections (67.5%). Efficacy was a significant factor in satisfaction, while cost was less influential.", "population_specificity": "140 men receiving TRT at a single institution.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:00.319403+00:00"}
{"study_id": 40499, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the long-term efficacy of testosterone replacement therapy (TRT) in improving sexual function and hypogonadal symptoms in middle-aged and older men with hypogonadism and low libido.", "results_summary": "TRT significantly improved sexual activity, hypogonadal symptoms, and sexual desire compared to placebo, with effects sustained at 24 months, but did not improve erectile function.", "population_specificity": "Middle-aged and older men (45-80 years) with hypogonadism (2 testosterone concentrations <300 ng/dL), hypogonadal symptoms, and cardiovascular disease or increased CVD risk, specifically those reporting low libido.", "effective_dosage": "1.62% testosterone gel (exact frequency not specified in abstract).", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:00.464745+00:00"}
{"study_id": 40500, "supplement_id": 1608, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effect of testosterone replacement therapy (TRT) on muscle strength and physical function in older men with low testosterone levels.", "results_summary": "TRT improved muscle strength in older, relatively hypogonadal men, with intramuscular administration showing greater efficacy than transdermal or oral options. Adverse events, including elevated prostate-specific antigen and prostate cancer, showed no significant difference compared to placebo.", "population_specificity": "Older men (age >60 years) with relatively low testosterone levels.", "effective_dosage": "Transdermal (5-10 g/day), intramuscular (125 mg/week or 200 mg every 2 weeks), oral (160 mg/day in one study).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:01.617073+00:00"}
{"study_id": 40504, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether testosterone replacement therapy (TRT) impacts treatment conversion rates in patients with localized prostate cancer on active surveillance.", "results_summary": "The study found no significant difference in conversion to treatment (24% vs. 21%) or treatment-free survival between TRT and non-TRT groups. PSA density was the only variable associated with treatment-free survival.", "population_specificity": "Patients with localized prostate cancer on active surveillance.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 5.82 years (IQR 3.27-9.30)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:01.797501+00:00"}
{"study_id": 40505, "supplement_id": 1608, "safety_score": "30", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association of testosterone replacement therapy (TTh) with cardiovascular disease (CVD) risk in cisgender women and transgender individuals, and whether this association varies by menopausal status.", "results_summary": "The study found a 24% increased risk of CVD, 26% risk of coronary artery disease, and 29% risk of stroke in cisgender women using TTh compared to nonusers. No increased CVD risk was observed in transgender individuals.", "population_specificity": "25,796 cisgender women and 1,580 transgender individuals (\u226530 years old).", "effective_dosage": "Not specified", "study_duration": "Data collected from 2007 to 2021 (follow-up duration not explicitly stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:05.099242+00:00"}
{"study_id": 40502, "supplement_id": 1608, "safety_score": "30", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether testosterone replacement therapy (TRT) in hypogonadal men affects the risk of developing vascular graft infections (VGIs) after prosthetic graft placement.", "results_summary": "The study found that hypogonadal men on TRT had a significantly higher risk of VGIs (14% vs. 8%) and lower 5-year freedom from infection compared to controls. Adjusted analysis showed TRT was associated with nearly double the risk of graft infection (HR: 1.94).", "population_specificity": "Men over 18 years who underwent prosthetic bypass graft procedures in the peripheral arterial circulation (2009\u20132020), with a subset diagnosed as hypogonadal (802 patients, 251 on TRT).", "effective_dosage": "Not specified", "study_duration": "TRT use within 180 days before surgery; follow-up duration not explicitly stated.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:05.101519+00:00"}
{"study_id": 40507, "supplement_id": 1608, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the cardiovascular safety of testosterone-replacement therapy in middle-aged and older men with hypogonadism and preexisting or high risk of cardiovascular disease.", "results_summary": "Testosterone-replacement therapy was noninferior to placebo in terms of major adverse cardiac events, with similar rates of primary and secondary cardiovascular endpoints. However, the testosterone group showed higher incidences of atrial fibrillation, acute kidney injury, and pulmonary embolism.", "population_specificity": "Men aged 45 to 80 with hypogonadism, preexisting or high risk of cardiovascular disease, and two fasting testosterone levels below 300 ng/dL.", "effective_dosage": "Daily transdermal 1.62% testosterone gel, adjusted to maintain testosterone levels between 350 and 750 ng/dL.", "study_duration": "Mean treatment duration of 21.7 months, mean follow-up of 33.0 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:06.572276+00:00"}
{"study_id": 40509, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of 12-month testosterone replacement therapy (TRT) on bone mineral density (BMD) and bone turnover markers in testicular cancer survivors with mild Leydig cell insufficiency.", "results_summary": "TRT did not significantly change BMD compared to placebo but was associated with a small, statistically significant increase in P1NP (a bone formation marker), which was deemed clinically irrelevant. No difference was observed in CTX (a bone resorption marker).", "population_specificity": "Testicular cancer survivors with mild Leydig cell insufficiency (n=69).", "effective_dosage": "Tostran gel (2%), applied transdermally, maximum daily dose of 40 mg.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:07.451815+00:00"}
{"study_id": 40511, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the impact of early hormonal treatment (EHT) and hormonal booster therapy (HBT) on behavioral symptoms in males with 49,XXXXY.", "results_summary": "The study found that testosterone replacement therapy (EHT and HBT) was associated with decreased behavioral complications, including somatic complaints, internalizing and externalizing problems, and withdrawn/depression, as measured by the Child Behavior Checklist. No differences were observed on the Behavior Rating Inventory of Executive Function.", "population_specificity": "Males aged 5-18 years with 49,XXXXY.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:09.456364+00:00"}
{"study_id": 40513, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review various testosterone treatment options, focusing on the role and pharmacokinetics of new oral formulations like JATENZO and TLANDO.", "results_summary": "The study highlights that JATENZO and TLANDO, as oral testosterone formulations, address limitations of other dosing routes and provide a safe option without evidence of liver dysfunction. The abstract suggests these formulations offer effective testosterone replacement with unique absorption mechanisms.", "population_specificity": "Males with hypogonadism (10-30% of the male population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:10.086739+00:00"}
{"study_id": 40512, "supplement_id": 1608, "safety_score": "80", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine if short-term adjunctive androgen therapy (TRT or oxandrolone) could improve rehabilitative outcomes in patients with ICU-associated weakness or hospital-associated deconditioning.", "results_summary": "The study found a mean grip strength improvement of 4.2 kg (+24.9%) over 2 weeks, along with functional recovery in ambulation and reduced need for assistance. Four of five subjects were biochemically hypogonadal, and no significant adverse events were reported.", "population_specificity": "Patients with ICU-associated weakness or hospital-associated deconditioning in a tertiary care hospital.", "effective_dosage": "Not specified", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:10.374259+00:00"}
{"study_id": 40510, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to identify predictors of Testosterone Replacement Therapy (TRT) efficacy in patients with late-onset hypogonadism (LOH).", "results_summary": "The study found that 80.4% of patients responded to TRT, with the testosterone/estradiol (T/E2) ratio being an independent predictive factor for treatment efficacy. A low T/E2 ratio was associated with reduced response, and a threshold of 17.3 was identified to predict nonresponders.", "population_specificity": "56 male patients with late-onset hypogonadism visiting a Men's Health Clinic in Japan.", "effective_dosage": "Not specified", "study_duration": "Data collected between November 2003 and June 2021 (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:10.739728+00:00"}
{"study_id": 40514, "supplement_id": 1608, "safety_score": "70", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the role of short-term testosterone replacement therapy in improving functional sarcopenia and survival rates in liver transplant recipients.", "results_summary": "The study found that testosterone deficiency exists post-liver transplant, with two-thirds of recipients showing low skeletal muscle index or density. Short-term testosterone replacement therapy combined with in-bed exercise resulted in 87.5% 5-year patient and graft survival.", "population_specificity": "Liver transplant recipients with functional sarcopenia.", "effective_dosage": "200 mg testosterone cypionate (1 dose for 12 patients, >1 dose for 4 patients).", "study_duration": "Short-term (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:13.765943+00:00"}
{"study_id": 40515, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the frequency of sexual dysfunction in congenital hypogonadism patients and assess the effect of short-term testosterone replacement therapy on sexual function using standardized scales.", "results_summary": "The study found a significant improvement in sexual function across all three assessment scales (ASEX, IIEF-5, IIEF-15) after testosterone therapy. The scales showed varying degrees of correlation before and after treatment, supporting their utility in evaluating sexual dysfunction in this population.", "population_specificity": "47 young male patients (aged >18 years) diagnosed with hypogonadotropic hypogonadism.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:13.932831+00:00"}
{"study_id": 40516, "supplement_id": 1608, "safety_score": "60", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to synthesize information on clinical depression, its treatment options, and evaluate the efficacy and safety of testosterone therapy for depression.", "results_summary": "Testosterone administration showed positive results in subpopulations like men with dysthymic disorder, treatment-resistant depression, or low testosterone levels, but some studies found no difference compared to placebo. Over-administration was linked to adverse effects.", "population_specificity": "Men with dysthymic disorder, treatment-resistant depression, or low testosterone levels; also referenced rodent models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:15.458741+00:00"}
{"study_id": 198429, "supplement_id": 1608, "safety_score": "60", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the role of Testosterone Replacement Therapy in addressing hypogonadism and related conditions, while assessing its risks and benefits.", "results_summary": "The study found that Testosterone Replacement Therapy can help manage symptomatic hypogonadism but carries risks such as azoospermia, polycythemia, and uncertain cardiovascular effects. Gynecomastia and sexual dysfunction were also discussed as potential outcomes of hormonal imbalances.", "population_specificity": "Males with hypogonadism or related endocrine disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:17.887254+00:00"}
{"study_id": 198431, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the prevalence of hypogonadism in male patients with metastatic renal cell carcinoma treated with sunitinib and evaluate the impact of testosterone replacement therapy (TRT) on their quality of life.", "results_summary": "The study found an increasing prevalence of hypogonadism with longer sunitinib treatment, and TRT significantly improved global quality of life in patients after 3 months of supplementation.", "population_specificity": "Male patients with metastatic renal cell carcinoma treated with sunitinib.", "effective_dosage": "Not specified", "study_duration": "3 months for TRT", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:18.368218+00:00"}
{"study_id": 40518, "supplement_id": 1608, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether testosterone replacement therapy (TRT) affects platelet aggregation and cardiovascular risk in men with Klinefelter syndrome (KS).", "results_summary": "The study found no increase in platelet aggregation in men with KS before or during TRT compared to a reference population, and no significant changes were observed after 18 months of TRT. Platelet aggregation was not associated with testosterone levels, and TRT did not affect platelet count, though slight differences were noted based on the route of administration (gel vs. injection).", "population_specificity": "Adult men with Klinefelter syndrome (KS), including those with no prior TRT, those on short-term TRT (18 months), and those on long-term TRT (>10 years).", "effective_dosage": "Not specified", "study_duration": "18 months for short-term TRT group; >10 years for long-term TRT group", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:18.573709+00:00"}
{"study_id": 198432, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the specific role of testosterone supplementation therapy (TST) in improving glycemic control and lipid profiles in hypogonadal men with type 2 diabetes mellitus (T2DM).", "results_summary": "The meta-analysis found that TST significantly improved glycemic control, reduced insulin resistance, lowered cholesterol and triglyceride levels, and increased total and free testosterone levels in hypogonadal T2DM patients. The results suggest TST may be beneficial alongside anti-diabetic treatment.", "population_specificity": "Hypogonadal men with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:19.075709+00:00"}
{"study_id": 198433, "supplement_id": 1608, "safety_score": "30", "efficacy_score": 25, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the quality of online information regarding Testosterone Replacement Therapy (TRT) for treating late-onset hypogonadism (LOH) in men.", "results_summary": "The study found that online TRT information was incomplete, often lacking important safety details and monitoring requirements. Only 5% of websites described TRT as safe, while 40% claimed benefits, and 25% stated it was effective for LOH.", "population_specificity": "Men seeking information on TRT for late-onset hypogonadism (LOH).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:19.612582+00:00"}
{"study_id": 198435, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to investigate the effectiveness of Testosterone Replacement Therapy in addressing gonadal axis deficiency and related symptoms (e.g., decreased libido, mood, and physical fitness) in a patient with post-traumatic hypopituitarism.", "results_summary": "Testosterone Replacement Therapy improved the patient's physical fitness, mood, and weight management, though growth hormone deficiency persisted, requiring additional treatment. The patient reported overall better well-being after therapy.", "population_specificity": "A 24-year-old male with a history of severe thoracic trauma and subsequent hypopituitarism.", "effective_dosage": "Not specified", "study_duration": "Ongoing (initiated in 2013, follow-up in 2016)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:23.623866+00:00"}
{"study_id": 198434, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to evaluate the effect of intramuscular testosterone enantholactam acid ester on Aging Males' Symptoms (AMS) scores in hemodialysis patients with late-onset hypogonadism (LOH).", "results_summary": "Testosterone treatment significantly improved total AMS scores compared to placebo (-13.2% vs. +1%) and showed notable improvement in somato-vegetative domain scores. The study suggests testosterone may be effective for improving health-related quality of life in hemodialysis patients with LOH.", "population_specificity": "Male hemodialysis patients with late-onset hypogonadism (LOH) and total AMS scores \u226527.", "effective_dosage": "250 mg intramuscular injection every 2 weeks.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:23.964350+00:00"}
{"study_id": 198437, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to highlight the need for long-term data on testosterone supplementation therapy (TST) to define appropriate populations and minimize inappropriate prescribing.", "results_summary": "The abstract does not present specific study results but emphasizes the FDA's request for more long-term data on TST's efficacy and safety to guide future prescribing practices.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:25.336671+00:00"}
{"study_id": 198436, "supplement_id": 1608, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of Testosterone Replacement Therapy in addressing androgen deficiency symptoms and its clinical management in men.", "results_summary": "The study found that restoring physiological testosterone levels improves symptoms like libido, fatigue, and wellbeing, with noticeable effects after 3-6 weeks. Close monitoring of testosterone, hematocrit, and PSA levels is recommended during therapy.", "population_specificity": "Men aged 40-79 years with biochemical deficiency and symptomatic hypogonadism.", "effective_dosage": "Not specified", "study_duration": "At least 3-6 weeks for symptom improvement, with follow-ups at 3, 6, and 12 months, then annually.", "interactions": "Statins, steroids, opioids, dopamine antagonists, 5-alpha reductase inhibitors, alcohol, anabolic steroids, and illicit substances like marijuana.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:25.560984+00:00"}
{"study_id": 198438, "supplement_id": 1608, "safety_score": "60", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to review current literature on testosterone replacement therapy, focusing on its implications for male fertility and safety concerns such as cardiovascular risks.", "results_summary": "The study found that testosterone replacement therapy can negatively impact spermatogenesis but is reversible upon cessation. Alternative treatments like selective estrogen receptor modulators or human chorionic gonadotropin may preserve fertility. The FDA has flagged potential risks of venous thromboembolism, cardiovascular events, and stroke.", "population_specificity": "Hypogonadal men, particularly those seeking fertility.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:27.218080+00:00"}
{"study_id": 198440, "supplement_id": 1608, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review the prevalence, diagnosis, treatment, and potential adverse effects of testosterone replacement therapy (TST) in hypogonadal men, with a focus on cardiovascular controversy.", "results_summary": "TST effectively improves signs and symptoms of hypogonadism, though maximum response may take 3 months to a year. Concerns remain about cardiovascular risks, requiring further studies.", "population_specificity": "Aging men with hypogonadism (low serum testosterone and associated symptoms).", "effective_dosage": "Not specified", "study_duration": "3 months to a year for maximum response", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:27.717217+00:00"}
{"study_id": 198441, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to summarize the evidence on late-onset hypogonadism (LOH) and its interaction with general health, focusing on the effects of testosterone replacement therapy (TRT) in various chronic conditions.", "results_summary": "The study suggests TRT may improve central obesity, glycometabolic control, lean body mass, insulin resistance, and peripheral oxygenation in specific populations, but notes limited evidence to draw definitive conclusions.", "population_specificity": "Aging males with LOH, often comorbid with obesity, type 2 diabetes mellitus (T2DM), metabolic syndrome (MetS), HIV, chronic obstructive pulmonary disease, and chronic kidney diseases.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:28.897730+00:00"}
{"study_id": 198444, "supplement_id": 1608, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to summarize the indications, contraindications, benefits, and risks of testosterone replacement therapy, focusing on transdermal administration, and compare various testosterone preparations.", "results_summary": "The study found that testosterone replacement therapy effectively reverses symptoms of hypogonadism (except infertility) and may alleviate associated comorbidities, with transdermal formulations providing more physiological testosterone concentrations. Patient compliance and monitoring are critical for clinical success.", "population_specificity": "Men with symptoms of hypogonadism (e.g., fatigue, decreased sexual desire, erectile dysfunction, reduced muscle mass).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:32.983255+00:00"}
{"study_id": 198445, "supplement_id": 1608, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to assess the risk of prostate carcinogenesis associated with testosterone replacement therapy in aging males.", "results_summary": "The abstract highlights concerns about testosterone therapy potentially triggering prostate cancer, given the high prevalence of prostate hyperplasia and occult prostate cancer in elderly men. It also notes the controversy due to undefined lower limits of normal testosterone levels and non-specific hypogonadal symptoms.", "population_specificity": "Aging males with late-onset hypogonadism.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:33.329315+00:00"}
{"study_id": 198446, "supplement_id": 1608, "safety_score": "65", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the potential benefits and risks of Testosterone Replacement Therapy (TRT) in men with late-onset hypogonadism.", "results_summary": "The study suggests TRT may improve libido, sexual function, bone density, muscle mass, mood, and quality of life, but highlights concerns about risks such as prostate cancer stimulation, benign prostatic hypertrophy, and erythrocytosis, despite limited evidence for some risks.", "population_specificity": "Men with late-onset hypogonadism.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:34.376019+00:00"}
{"study_id": 50173, "supplement_id": 1610, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the immunomodulatory effects of Tetraselmis Chuii, both alone and in combination with Bacillus subtilis, on gilthead sea bream.", "results_summary": "Tetraselmis Chuii exhibited up-regulating effects on immune parameters in gilthead sea bream, though P. tricornutum showed higher immunostimulant activity. No significant differences were found between combination feeding and feeding ingredients separately.", "population_specificity": "Gilthead sea bream (fish)", "effective_dosage": "100 g kg(-1) of diet", "study_duration": "Two and four weeks of treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:36.058100+00:00"}
{"study_id": 50172, "supplement_id": 1610, "safety_score": "90", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety of TetraSOD\u00ae (Tetraselmis chuii) as a potential food ingredient through a 90-day oral toxicology study in rats.", "results_summary": "The study found no treatment-related mortality, clinical signs, or adverse effects on haematology, blood biochemistry, organ weights, or histopathology at doses up to 2500 mg/kg/day, with a NOAEL exceeding the highest tested dose.", "population_specificity": "Rats", "effective_dosage": "625, 1667, or 2500 mg/kg/day", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:36.519484+00:00"}
{"study_id": 198439, "supplement_id": 1608, "safety_score": "70", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to explore the relationship between testosterone replacement therapy (TRT) and recurrent prostate cancer risk in hypogonadal men with a history of prostate cancer.", "results_summary": "TRT increased testosterone levels without significant PSA elevation in most patients, though select high-risk and metastatic cases showed PSA increases without disease progression. The study suggests potential benefits for TRT in symptomatic hypogonadal men with a history of prostate cancer, but data limitations caution definitive conclusions.", "population_specificity": "Hypogonadal men with a history of prostate cancer, primarily localized disease treated with radical prostatectomy or radiotherapy, with some high-risk and metastatic cases included.", "effective_dosage": "Varied dosages and dosage forms (not specified in detail).", "study_duration": "Up to nine years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:37.130812+00:00"}
{"study_id": 198409, "supplement_id": 1610, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Tetraselmis chuii supplementation on hematological, anthropometric, and hormonal parameters in healthy young men.", "results_summary": "Tetraselmis chuii supplementation at 25 mg/day and 200 mg/day led to significant increases in muscle mass, erythropoietin, insulin-like growth factor 1, free testosterone, leukocytes, neutrophils, and lymphocytes, while decreasing fat mass, platelets, hematocrit, and mean corpuscular hemoglobin. The 25 mg/day dose appeared most effective.", "population_specificity": "Healthy young men (ages ~20-21, n=46).", "effective_dosage": "25 mg/day and 200 mg/day.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:38.657937+00:00"}
{"study_id": 40619, "supplement_id": 1612, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether maternal omega-3 fatty acid supplementation could mitigate THC-induced fetal growth and postnatal cardiac deficits in offspring.", "results_summary": "The study found that maternal THC exposure led to decreased birthweight and early cardiac deficits in offspring, but omega-3 fatty acid supplementation ameliorated these effects, potentially through alterations in fatty acid metabolism and reduced cardiac collagen deposition.", "population_specificity": "Pregnant subjects (preclinical model) and their offspring.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:40.769981+00:00"}
{"study_id": 40621, "supplement_id": 1612, "safety_score": "65", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess whether the CB1 receptor antagonist selonabant (ANEB-001) could effectively block THC-induced effects in healthy adults.", "results_summary": "Selonabant significantly reduced THC-induced \"Feeling High\" and improved alertness, while also reducing body sway. It was generally safe, though nausea and vomiting occurred more frequently at higher doses, with 10-mg selonabant being well-tolerated and efficacious.", "population_specificity": "Healthy adults", "effective_dosage": "Part A: 10.5 mg THC with 50 mg or 100 mg selonabant; Part B: 21 mg THC with 30 mg or 10 mg selonabant", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:42.147274+00:00"}
{"study_id": 40622, "supplement_id": 1612, "safety_score": "90", "efficacy_score": 95, "quality_score": 92, "study_goal": "The researchers aimed to evaluate the therapeutic efficacy and safety of a transdermal medical cannabis formulation (THC:CBD:CBN) for treating painful diabetic peripheral neuropathy (DPN) in the lower extremities.", "results_summary": "The cannabis formulation significantly reduced pain intensity (NPSI-T scores decreased from 25.60 to 5.57) compared to placebo (25.24 to 22.85), with minimal adverse events (10% mild effects) and an excellent safety profile.", "population_specificity": "100 participants with painful DPN of the lower extremities.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:43.522382+00:00"}
{"study_id": 40625, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether rising THC concentrations in cannabis in Germany were associated with an increase in cannabis-related mental health diagnoses.", "results_summary": "The study found that higher THC concentrations were significantly associated with increased cannabis-related diagnoses, with a stronger effect observed in men. THC concentration positively predicted diagnoses in nearly all federal states for both sexes.", "population_specificity": "Statutory health insurance enrollees in Germany (2009\u20132021) with cannabis-related ICD-10 F12 diagnoses.", "effective_dosage": "Not specified (THC concentration in cannabis flower analyzed, not dosage per individual).", "study_duration": "Observational period spanned 12 years (2009\u20132021).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:46.083318+00:00"}
{"study_id": 40626, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of repeated THC vapor inhalation on thermal nociception and mechanical sensitivity in a chronic inflammatory pain model using rats.", "results_summary": "Repeated THC vapor inhalation rescued thermal hyperalgesia in both male and female rats and reduced mechanical hypersensitivity in males but not females. Many antihyperalgesic effects persisted 24 hours after the last THC exposure, and these effects were blocked by the cannabinoid type-1 receptor inverse agonist AM251.", "population_specificity": "Adult male and female Wistar rats with chronic inflammatory pain induced by complete Freund's adjuvant (CFA).", "effective_dosage": "Not specified", "study_duration": "Not specified (repeated inhalation over multiple days, with effects assessed after the first and tenth days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:48.320016+00:00"}
{"study_id": 40627, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of chronic prenatal THC exposure on fetal and infant musculoskeletal development.", "results_summary": "Prenatal THC exposure had limited overall effects on muscle development but showed the greatest impact on inflammation and cytokine signaling pathways, suggesting potential tissue damage and atrophy. The study provides a basis for further research on long-term implications.", "population_specificity": "Non-human primates (fetal and infant stages)", "effective_dosage": "Not specified", "study_duration": "Chronic prenatal exposure (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:48.463127+00:00"}
{"study_id": 40624, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether voluntary co-use of low to moderate levels of ethanol and THC during adolescence would impact AKT and GSK3\u00df signaling in the mPFC and MBH, and whether these effects persisted into adulthood.", "results_summary": "THC challenge increased phosphorylated levels of AKT and GSK3\u00df similarly across all treatment groups, sexes, and brain regions, with no effects on total protein levels. The study found no long-term deficits in working memory or metabolic signaling due to moderate co-use of alcohol and THC.", "population_specificity": "Peri-adolescent Long Evans rats (postnatal day 30-47).", "effective_dosage": "THC (3-10 mg/kg/day) via cookies; challenge dose of 5 mg/kg THC (i.p.).", "study_duration": "17 days (P30-47), with follow-up until P114.", "interactions": "Co-use with ethanol (10% concentration).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:50.298154+00:00"}
{"study_id": 40628, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine if THC or high-THC cannabis extract could synergize with cisplatin to enhance treatment efficacy in colorectal cancer cell lines.", "results_summary": "The study found an antagonistic interaction between high-THC cannabis extract and cisplatin in colorectal cancer cell lines, linked to altered gene transcription in cell death, DNA repair, and drug resistance pathways.", "population_specificity": "HT-29, HCT-116, and LS-174T colorectal cancer cell lines", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Antagonistic interaction with cisplatin", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:50.479523+00:00"}
{"study_id": 40629, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the pharmacodynamics of HHC epimers and \u03949-THC, focusing on their CB1R-mediated signaling pathways and potential therapeutic applications.", "results_summary": "The study found that HHC epimers activate CB1R but have unique properties compared to \u03949-THC, with greater chemical stability, suggesting potential for modern medical use.", "population_specificity": "Not specified (pharmacological study, likely in vitro or animal models).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:51.519667+00:00"}
{"study_id": 198443, "supplement_id": 1608, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of testosterone supplementation on autonomic balance (assessed via heart rate variability) in men with metabolic syndrome and testosterone deficiency syndrome.", "results_summary": "Testosterone supplementation significantly improved several HRV parameters (SDNN, SDANN, TP, LF, ULF, and VLF domains) in men with MS and TDS, though values remained below those of healthy controls. Total and free testosterone levels were unaffected by treatment.", "population_specificity": "80 men divided into three groups: those with metabolic syndrome and testosterone deficiency (MS+TDS+), those with metabolic syndrome but no testosterone deficiency (MS+TDS-), and healthy controls.", "effective_dosage": "Intramuscular testosterone therapy (Omnadren 250)", "study_duration": "9 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:51.818680+00:00"}
{"study_id": 40630, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the effects of THC on autonomic nervous system regulation and central pain modulation in patients with chronic radicular neuropathic pain.", "results_summary": "THC significantly reduced the LF/HF heart rate variability ratio (indicating increased parasympathetic tone) and improved conditioned pain modulation responses. The autonomic changes correlated with increased functional connectivity in brain regions involved in pain regulation.", "population_specificity": "Twelve male patients with chronic radicular neuropathic pain.", "effective_dosage": "0.2 mg/kg sublingual THC (single administration).", "study_duration": "Single-administration trial (acute effects measured).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:54.401734+00:00"}
{"study_id": 40631, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to evaluate THC's potential as adjunctive therapy in various medical illnesses and identify weaknesses in existing clinical trials.", "results_summary": "The study highlights THC's diverse pharmacologic potential but notes significant methodological flaws in trials, such as small sample sizes, short duration, and poorly defined outcomes. It underscores the need for better-designed studies to confirm safety and efficacy.", "population_specificity": "Not specified (general medical illnesses)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:55.920436+00:00"}
{"study_id": 40632, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to investigate the impact of in vitro THC exposure on sperm function and embryo development following IVF.", "results_summary": "THC reduced mitochondrial membrane potential in sperm at high recreational doses (4.8\u03bcM) and altered fertility-associated microRNAs. Blastocysts from THC-exposed sperm had fewer trophoblasts and inner cell mass cells, suggesting negative effects on embryo quality.", "population_specificity": "Bovine sperm (as a translational model for human sperm).", "effective_dosage": "0.032\u03bcM (therapeutic), 0.32\u03bcM (low recreational), and 4.8\u03bcM (high recreational).", "study_duration": "6 hours of THC exposure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:57.437573+00:00"}
{"study_id": 40633, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anticonvulsant effects of CBD alone and in combination with \u03949-THC, as well as the role of 5-HT1A receptors in CBD's mechanism of action.", "results_summary": "The study found that \u226530 \u00b5M CBD alone had significant anticonvulsant effects, while 10 \u00b5M CBD combined with low-dose \u03949-THC (20:3 ratio) showed greater efficacy than either cannabinoid alone. Blocking 5-HT1A receptors abolished CBD's effects, indicating its mechanism involves these receptors.", "population_specificity": "Mouse brain slices (cortex layer 2/3)", "effective_dosage": "10, 30, and 100 \u00b5M CBD alone; 10 \u00b5M CBD combined with \u03949-THC (20:3 ratio)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:00.596146+00:00"}
{"study_id": 40635, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the performance of POCT devices in detecting THC from oral medicinal cannabis use and assess the likelihood of positive THC results after consumption.", "results_summary": "The study found large variability in OF THC concentrations post-treatment, with poor sensitivity (25-50%) of POCT devices at 0.5h. All THC concentrations fell below screening cut-offs by 10h and 18h post-treatment, indicating low probability of positive results the morning after use.", "population_specificity": "Adults with insomnia disorder (n=20)", "effective_dosage": "Single 10mg THC + 200mg CBD oral dose", "study_duration": "Single administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:00.804510+00:00"}
{"study_id": 40636, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether longer photoperiods (13 h vs. 12 h) could increase inflorescence yields in THC-dominant cannabis cultivars without reducing cannabinoid concentrations.", "results_summary": "The study found that a 13 h photoperiod significantly increased inflorescence yields (1.35-1.50 times higher) compared to 12 h, with no decrease in cannabinoid concentrations. Flowering initiation and maturation timing varied slightly between cultivars.", "population_specificity": "Indoor-grown THC-dominant cannabis cultivars ('Incredible Milk' and 'Gorilla Glue').", "effective_dosage": "Not specified (study focused on photoperiod and light intensity).", "study_duration": "Until commercial maturity (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:01.144093+00:00"}
{"study_id": 40634, "supplement_id": 1612, "safety_score": "65", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of oral consumption of whole Cannabis, a complex Cannabis extract, and purified THC/CBD on neurochemicals, endocannabinoids, and physiological parameters in mice.", "results_summary": "The study found changes in neurochemicals and endocannabinoids at all doses, with varying effects based on treatment type. THC and 11-OH-THC levels were higher in mice receiving 1:1 THC:CBD by i.p. injection, and tryptophan levels decreased across all Cannabis-treated groups.", "population_specificity": "C57BL/6J mice", "effective_dosage": "0-100 mg/kg/day CBD with THC levels \u22641.2 mg/kg/day (free feeding and gavage) or 10 mg/kg/day (i.p. injection)", "study_duration": "2 weeks (every other day)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:01.763127+00:00"}
{"study_id": 40637, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the impact of prenatal THC exposure on obesity risks in male and female rats during adolescence using an inhalation model.", "results_summary": "Prenatal THC exposure led to altered activity levels, with low-dose THC reducing dark-cycle activity and higher doses increasing locomotion. It also had dose-dependent effects on maternal weight gain and birth weight, suggesting potential developmental impacts linked to obesity risks later in life.", "population_specificity": "Pregnant rats and their offspring (male and female).", "effective_dosage": "10 mg THC (low dose) and 40 mg THC (high dose), administered via daily 10-minute inhalations.", "study_duration": "From gestational day 2 through birth.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:03.535819+00:00"}
{"study_id": 40638, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the lasting impact of adolescent THC exposure on the brain's reaction to viral infection in mice.", "results_summary": "Adolescent THC exposure lessened the fever response to a viral mimic in female mice and prevented male-selective downregulation of neuron-related genes caused by the viral mimic. THC also dampened the brain's antiviral response in females but did not affect locomotor responses in either sex.", "population_specificity": "Male and female mice (adolescent to adulthood)", "effective_dosage": "5 mg/kg, intraperitoneal, once daily", "study_duration": "14 days (postnatal day 30-43)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:04.777071+00:00"}
{"study_id": 40639, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to analyze the composition of acid-treated CBD mixtures and commercial \u03948-THC gummies to identify the presence of various cannabinoid isomers and assess regulatory concerns.", "results_summary": "The study found that acid-treated CBD mixtures contained varying levels of \u03948-THC, high levels of \u03949-THC, and other isomers like \u03948-iso-THC and \u0394(4)8-iso-THC. Commercial \u03948-THC gummies exhibited issues such as overclaimed \u03948-THC content, excessive \u03949-THC, and undeclared isomers.", "population_specificity": "Not specified (laboratory analysis of chemical mixtures and commercial products)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:06.338499+00:00"}
{"study_id": 40623, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the anti-inflammatory and neuroprotective effects of NTI-164 (a high-CBD, low-THC extract) and CBD alone on microglia and neurons.", "results_summary": "NTI-164 significantly attenuated inflammation-induced up-regulation of microglial markers and promoted neuron proliferation and survival under excitotoxic conditions, while CBD alone did not show these effects.", "population_specificity": "BV-2 microglia and SHSY-5Y neurons (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:06.747940+00:00"}
{"study_id": 40641, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate protein abundance differences in human neuroblastoma cells treated with THC to understand its biological effects.", "results_summary": "The study found that THC treatment led to significant protein regulation, potentially causing mitochondrial dysfunction and endoplasmic reticulum stress in SH-SY5Y cells. These findings suggest THC may influence cellular stress pathways.", "population_specificity": "Human neuroblastoma SH-SY5Y cell line", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:08.360960+00:00"}
{"study_id": 40640, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the intracellular mechanisms by which THC and LPI activate GPR55, leading to altered Ki67+ nuclei in human glioblastoma cells.", "results_summary": "THC exerted antitumor effects by inhibiting tumor cell proliferation and inducing apoptosis via GPR55 activation, with cell-type-specific differences in signaling pathways (PLC-IP3, G\u03b1-, G\u03b2\u03b3-, RhoA-ROCK, and calcineurin). NFAT subcellular localization remained unchanged after THC or LPI treatment.", "population_specificity": "Human glioblastoma cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:09.320378+00:00"}
{"study_id": 40642, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine how nitrogen nutrition and pruning affect cannabinoid concentrations and biomass in a commercial cannabis cultivar.", "results_summary": "Higher nitrogen supply decreased cannabinoid concentration and yield per plant, while pruning did not affect biomass or cannabinoid levels. Plants with more sunlight exposure developed higher biomass and cannabinoid concentrations.", "population_specificity": "Clones of a Cannabis sativa L. (CBD-type) grown in a controlled-environment glasshouse.", "effective_dosage": "Nitrogen rates of 30, 60, 210, and 500 mg/L applied for twelve weeks.", "study_duration": "Twelve weeks after five weeks of vegetative growth.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:09.598639+00:00"}
{"study_id": 40643, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficiency and safety of concomitant treatment with irinotecan (IRI) and THC in a colorectal cancer mouse model.", "results_summary": "Combining THC with IRI reduced IRI's efficiency in inhibiting tumor growth. THC did not mitigate IRI-induced systemic toxicity, which included weight loss and high oxidative stress.", "population_specificity": "Male BALB/c mice with subcutaneously injected CT26 colorectal cancer cells.", "effective_dosage": "7 mg/kg THC by gavage daily for 7 days.", "study_duration": "7 days.", "interactions": "THC diminished the antitumor efficiency of irinotecan (IRI).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:10.834415+00:00"}
{"study_id": 40644, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether \u03948-THC could counteract neuronal cell death and promote recovery in a traumatic scratch injury model using NSC-34 motoneuron cells.", "results_summary": "The study found that \u03948-THC triggered cytoskeletal remodeling, likely through activation of the JAK/STAT and MAP kinase signaling pathways, suggesting it could counteract traumatic neuronal cell death in motoneuron cells.", "population_specificity": "NSC-34 motoneuron cell line (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:11.452927+00:00"}
{"study_id": 40645, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of prolonged oral administration of THC on obesity-related parameters and peripheral endocannabinoids in mice.", "results_summary": "THC attenuated weight gain, improved glucose tolerance, reduced steatosis markers, and decreased hypertrophic cells in adipose tissue. These effects suggest THC may ameliorate diet-induced obesity and metabolic parameters.", "population_specificity": "C57BL/6 male mice fed either a high-fat or standard diet.", "effective_dosage": "10 mg/kg for 5 weeks followed by 30 mg/kg for an additional 5 weeks.", "study_duration": "10 weeks total.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:13.442663+00:00"}
{"study_id": 40647, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether adolescent THC exposure in mice leads to cannabis addiction-like behavior and impulsivity in adulthood, along with associated gene expression changes.", "results_summary": "Adolescent THC exposure did not increase cannabis addiction-like behavior but was linked to heightened impulsivity in adulthood and downregulation of drd2 and adora2a genes in specific brain regions.", "population_specificity": "Adolescent male mice", "effective_dosage": "5 mg/kg THC (postnatal days 37-57)", "study_duration": "20 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:14.563089+00:00"}
{"study_id": 40646, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether repeated THC exposure alters nicotine self-administration and its reinforcing effects in rats.", "results_summary": "Post-session THC decreased nicotine self-administration in rats and increased the latency to stable nicotine intake, while pre-session THC suppressed responding at higher nicotine doses. THC did not affect sucrose responding post-session but reduced it pre-session, particularly in THC-na\u00efve rats.", "population_specificity": "Adult male and female Sprague-Dawley rats", "effective_dosage": "0, 3, 30 mg/kg THC daily", "study_duration": "14 days prior to and during nicotine self-administration training", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:14.962702+00:00"}
{"study_id": 40648, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effectiveness of THC in improving pain and psychometric variables in fibromyalgia syndrome (FMS) patients undergoing interdisciplinary multimodal pain therapy (IMPT).", "results_summary": "THC significantly improved pain intensity, depression, and quality of life in FMS patients compared to non-THC users, and it led to dose reductions or discontinuation of analgesics in five of seven groups. The improvements were statistically significant (p < 0.001).", "population_specificity": "120 FMS patients (62 treated with THC) in a pain ward undergoing interdisciplinary multimodal pain therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:17.354441+00:00"}
{"study_id": 40650, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether oral dronabinol (BX-1) is effective and safe in reducing nightmares and other PTSD symptoms in patients with PTSD.", "results_summary": "The study found preliminary evidence that cannabinoid agonists like dronabinol may improve nightmares and overall PTSD symptoms, though full results are pending as it is an ongoing trial.", "population_specificity": "Patients with PTSD experiencing distressing nightmares.", "effective_dosage": "Once-daily oral dose before bedtime (specific amount not provided).", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:18.735145+00:00"}
{"study_id": 40649, "supplement_id": 1612, "safety_score": "45", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess adverse events related to delta-8-THC use by comparing reports from a Reddit forum and the FDA Adverse Event Reporting System (FAERS).", "results_summary": "The study found that delta-8-THC adverse events were similar to those of cannabis, with psychiatric, respiratory, and nervous system disorders being the most common. The absolute number of adverse events reported on Reddit was higher than in FAERS.", "population_specificity": "Users of delta-8-THC who posted on the r/Delta8 Reddit forum and those who reported adverse events in FAERS.", "effective_dosage": "Not specified", "study_duration": "Data collected from August 20, 2020, to September 25, 2022.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:19.168624+00:00"}
{"study_id": 40651, "supplement_id": 1612, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether THC and CBD directly impact steroidogenic function and germ cell lineage in the human adult testis.", "results_summary": "The study found no acute direct effects of THC or CBD on testicular testosterone production, germ cell differentiation, or overall testis morphology after short-term exposure. No changes in apoptosis, cell proliferation, or gene expression related to testicular functions were observed.", "population_specificity": "Adult male multi-organ donors (n=13; mean age: 55.15\u00b15.62 years).", "effective_dosage": "THC concentrations from 10^-9 to 10^-5 M.", "study_duration": "Up to 48 hours or 9 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:20.225323+00:00"}
{"study_id": 40652, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the activation of CB1 receptors by cannabis terpenes individually and in combination with THC, and whether terpenes modulate THC's interaction with CB1 receptors.", "results_summary": "The study found that all tested terpenes individually activated CB1 receptors at 10-50% of THC's activation level. Some terpenes, when combined with THC, significantly amplified CB1 receptor activation, suggesting a synergistic effect. The most effective terpenes were not necessarily the most abundant in cannabis, indicating that selective terpene enrichment could enhance therapeutic effects.", "population_specificity": "In-vitro heterologous expression system (not human or animal subjects)", "effective_dosage": "Not specified (terpene to THC ratios similar to those in cannabis plant)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:21.206342+00:00"}
{"study_id": 40653, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to develop a model to predict stable THC and CBD dosages after six months of treatment using baseline patient characteristics.", "results_summary": "The study found that daily THC and CBD doses were significantly higher in the inhalation group compared to the sublingual group, but models based on patient characteristics failed to accurately predict final titration doses for either administration method. Male gender, unemployed status, tobacco smoking, and lack of concern about cannabis treatment were associated with higher inhaled THC doses.", "population_specificity": "Adult patients (age 18 and above) exclusively using either inhaled cannabis or sublingual oil.", "effective_dosage": "Not specified (only relative differences between groups reported).", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:22.619859+00:00"}
{"study_id": 40654, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 40, "study_goal": "The researchers aimed to evaluate the effects of a cannabis oil containing THC and CBD on chronic orthopedic pain in a cat.", "results_summary": "The treatment resulted in a more than 50% reduction in the FMPI scale score, indicating significant pain relief, though potential ALT elevation was noted.", "population_specificity": "A 10-year-old mixed breed male cat with chronic orthopedic pain.", "effective_dosage": "0.5 mg/kg based on CBD (1.8% CBD and 0.8% THC).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:22.738469+00:00"}
{"study_id": 40655, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine how THC, alone or in combination with cART, alters the abundance and compartmentalization of extracellular miRNAs in SIV-infected rhesus macaques.", "results_summary": "THC treatment significantly altered the abundance and compartmentalization of exmiRNAs in EVs and ECs, with distinct effects compared to cART alone or combined treatment. THC influenced specific miRNAs related to disease processes, suggesting potential biomarker utility.", "population_specificity": "Male Indian rhesus macaques (RMs) infected with SIV.", "effective_dosage": "Not specified", "study_duration": "Longitudinal analysis at 1 and 5 months post-infection (MPI)", "interactions": "Combined effects with cART were noted, but no specific interactions with medications, foods, or supplements were mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:24.679072+00:00"}
{"study_id": 40656, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of chronically inhaled vaporized cannabis on brain structure in adult female mice.", "results_summary": "The study found volumetric changes in the forebrain, including the prefrontal cortex, accumbens, ventral pallidum, and limbic cortex, along with alterations in gray matter microarchitecture, suggesting potential neurobiological effects of chronic cannabis use.", "population_specificity": "Adult female mice", "effective_dosage": "10.3% THC and 0.05% CBD, daily exposure", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:25.434910+00:00"}
{"study_id": 40658, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether peripubertal THC exposure affects the impact of prenatal or perinatal THC exposure on adult rats, particularly in relation to schizophrenia-like behaviors and dopaminergic signaling.", "results_summary": "The study found that prenatal and perinatal THC exposure led to schizophrenia-like behaviors (social withdrawal, cognitive impairment) and altered gene expression in adult rats. Peripubertal THC impaired social behavior in control rats but reversed cognitive deficits in MAM-exposed rats by modulating dopaminergic gene expression.", "population_specificity": "Adult rats exposed to prenatal methylazoxymethanol acetate (MAM) or perinatal THC (pTHC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:28.254750+00:00"}
{"study_id": 40657, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether symptoms of depression, anxiety, or comorbid depression and anxiety were associated with future use of THC in e-cigarettes among youth and young adults.", "results_summary": "Symptoms of depression and comorbid depression and anxiety at baseline were significantly associated with THC use in e-cigarettes 12 months later. Anxiety symptoms alone were not significantly associated with THC use.", "population_specificity": "Youth and young adults (16-23 years old) in urban areas of Texas, 58.1% female and 37.9% Hispanic.", "effective_dosage": "Not specified", "study_duration": "12-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:28.395913+00:00"}
{"study_id": 40659, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of THC exposure on sperm parameters, capacitation, apoptosis, and transcript levels in bull sperm as a translational model for human sperm.", "results_summary": "THC exposure did not alter sperm motility, morphology, or viability but increased capacitation at 0.32\u00b5M and altered gene expression at various doses, suggesting potential adverse effects on sperm function.", "population_specificity": "Bull sperm of known fertility (used as a translational model for human sperm).", "effective_dosage": "0.032\u00b5M, 0.32\u00b5M, and 3.2\u00b5M THC.", "study_duration": "Not specified (in vitro treatment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:29.744948+00:00"}
{"study_id": 40660, "supplement_id": 1612, "safety_score": "60", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the neurobiological and behavioral effects of chronic inhaled THC on the aging brain, focusing on analgesia, anxiety, cognition, and dopaminergic system plasticity.", "results_summary": "Chronic THC exposure provided sustained antinociceptive effects without tolerance but showed waning anxiolytic and cognitive effects. It reduced midbrain dopaminergic volume and gray matter, with partial recovery after cessation. CBD did not affect behavior but enhanced global network connectivity persistently.", "population_specificity": "Aging mice (19-20 months old)", "effective_dosage": "Vaporized cannabis containing ~10% THC, administered for 30 minutes daily", "study_duration": "28 days of exposure, plus a two-week washout period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:30.677385+00:00"}
{"study_id": 40661, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether THC affects dendritic spine dynamics and stability in an age-dependent manner, potentially explaining its differential effects on learning abilities in young and old mice.", "results_summary": "In old mice, THC improved spine stability and increased spine density long-term, while in young mice, it transiently increased spine turnover and destabilized spines. The study suggests THC has age-dependent effects on dendritic spine dynamics.", "population_specificity": "3- and 18-month-old mice", "effective_dosage": "3 mg/kg/day", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:30.880386+00:00"}
{"study_id": 40663, "supplement_id": 1612, "safety_score": "80", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the clinical efficacy and safety of THC:CBD cannabis extract in alleviating severe symptoms like agitation, weight loss, cognitive impairment, and sleep disturbance in Alzheimer's disease (AD) patients.", "results_summary": "The study found significant reductions in agitation, apathy, irritability, sleep disturbances, and eating disturbances, along with decreased physically and verbally aggressive behaviors. Cognitive impairment also improved significantly in 45% of patients.", "population_specificity": "30 AD patients (9 men, 21 women), aged 65-90, with mild to severe symptoms.", "effective_dosage": "Bedrocan\u00ae (22% THC, 0.5% CBD, Olive Oil 50 ml), twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:34.089218+00:00"}
{"study_id": 40664, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate hair concentrations of THC and THC-COOH and their correlations with age, gender, consumption habits, and hair features.", "results_summary": "The study found that cannabinoid levels in hair decreased with age and were lower in subjects over 40, while higher levels were observed in long-term consumers (>10 years). Bleached hair showed significantly reduced THC and THC-COOH concentrations.", "population_specificity": "Subjects tested for THC consumption for personal purposes (e.g., workplace drug testing, personal use proving).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:35.273320+00:00"}
{"study_id": 40665, "supplement_id": 1612, "safety_score": "75", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of THC on in vitro bovine granulosa cell viability, apoptosis, and stress response pathways, particularly under cortisol-induced stress conditions.", "results_summary": "THC did not affect cell viability or apoptosis. High and low cortisol increased 11\u03b2-HSD1 mRNA expression, but high THC reduced this effect. Low THC maintained increased GR expression under cortisol treatments.", "population_specificity": "In vitro bovine granulosa cells", "effective_dosage": "Clinically relevant therapeutic and recreational plasma doses (specific amounts not detailed)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:37.305538+00:00"}
{"study_id": 40666, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of THC, alone and in combination with CBD, on peripheral neuropathic pain in patients who had failed previous treatments.", "results_summary": "THC did not significantly reduce pain compared to placebo, with an effect size of 0.38 NRS points (95% CI -0.65 to 1.4), indicating minimal efficacy. The study concluded that THC did not relieve peripheral neuropathic pain in the studied population.", "population_specificity": "Patients with painful polyneuropathy, post-herpetic neuralgia, or peripheral nerve injury who had failed at least one previous evidence-based pharmacological treatment.", "effective_dosage": "THC 2.5-25 mg daily (flexible dosing).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:38.152460+00:00"}
{"study_id": 40667, "supplement_id": 1612, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of prenatal THC exposure on fetal nervous system development, specifically focusing on hippocampal neurodevelopment and neural stem cell differentiation.", "results_summary": "THC exposure altered neuronal cell composition and organization in the offspring hippocampus, affected gene expression related to neurogenesis, and impaired neural stem cell differentiation, which was regulated by the MEF2C pathway via CB1R activation. Pretreatment with the CB1R inhibitor Rimonabant rescued these effects.", "population_specificity": "Pregnant mice and their offspring.", "effective_dosage": "Not specified.", "study_duration": "Gestational day 5.5 to 12.5.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:39.065975+00:00"}
{"study_id": 40668, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether cannabinoid-based medicines (CBMs) containing THC and cannabidiol could modulate affective pain processing in epidermolysis bullosa (EB) patients, as measured by pain scores and fMRI.", "results_summary": "The abstract does not report results, as the study appears to be ongoing or not yet completed. Outcomes will include pain scores, self-efficacy, medication use, adverse events, and fMRI data.", "population_specificity": "Adult patients with epidermolysis bullosa (EB) reporting chronic pain.", "effective_dosage": "Sublingual Transvamix\u00ae (specific dosage not mentioned).", "study_duration": "Two weeks per intervention (placebo and Transvamix\u00ae), separated by a washout.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:40.204446+00:00"}
{"study_id": 40669, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the long-term effects of adolescent THC exposure on adult decision-making and impulse control using both human and rat models.", "results_summary": "Chronic cannabis users exhibited disadvantageous decision-making compared to controls, with increased reward learning and exploration-focused strategies. Rats exposed to high-dose THC during adolescence showed similar risky decision-making and cognitive impairments upon reexposure in adulthood, linked to altered reward learning and molecular changes in brain regions.", "population_specificity": "Human chronic cannabis users (n=22) and adolescent rats exposed to THC.", "effective_dosage": "High-dose and low-dose THC in rats (specific amounts not detailed in abstract).", "study_duration": "Data collected from 2017-2020, analyzed 2020-2022 (intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:41.568361+00:00"}
{"study_id": 40670, "supplement_id": 1612, "safety_score": "30", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to examine the retail sales environment of Delta-8 THC in Fort Worth, Texas, focusing on pricing, socioeconomic disparities in retail locations, and minimum age requirements.", "results_summary": "Eleven percent of outlets sold Delta-8 THC, with most selling vapes/flower or edibles. Outlets selling Delta-8 THC were disproportionately located in areas with greater socioeconomic deprivation, and some had lax age restrictions (4% allowed purchases under 21).", "population_specificity": "Retail outlets in Fort Worth, Texas, with alcohol, cannabidiol, and/or tobacco licenses.", "effective_dosage": "Not specified", "study_duration": "Data collected in September and October 2021 (cross-sectional study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:43.209433+00:00"}
{"study_id": 40671, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of THC-predominant cannabis flos (KHIRON 20/1) on patient-reported outcomes, including quality of life, mood, sleep, pain, and anxiety in a treatment-resistant clinical population.", "results_summary": "Inhalation of KHIRON 20/1 was associated with significant improvements in health-related quality of life, general mood, sleep, pain severity, and anxiety symptoms, with statistically significant results (p < 0.001) across all measured outcomes.", "population_specificity": "Mostly male (77.6%) patients with an average age of 38.3, diagnosed primarily with chronic pain (50.9%) and anxiety-related disorders (25.3%).", "effective_dosage": "Not specified", "study_duration": "3-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:44.990166+00:00"}
{"study_id": 40672, "supplement_id": 1612, "safety_score": "60", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether THC-induced anxiety is influenced by baseline anxiety levels and whether CBD mitigates THC's anxiogenic effects.", "results_summary": "THC and THC/CBD increased self-rated state anxiety compared to placebo, but THC/CBD caused less anxiety than THC alone. CBD counteracted THC-induced anxiety only when baseline anxiety was low.", "population_specificity": "26 healthy recreational cannabis users", "effective_dosage": "13.75 mg THC, 13.75 mg CBD, or 13.75 mg THC/13.75 mg CBD (single dose)", "study_duration": "Single administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:45.389637+00:00"}
{"study_id": 40673, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the rates of accidental and intentional unblinding in a randomized controlled trial (RCT) using THC-containing cannabinoids.", "results_summary": "The study found that 17% of participants experienced unblinding (either accidental or intentional), with 13% occurring during the treatment phase. Only 34% of participants were aware of the possibility of self-unblinding, and among those aware, 33% intentionally unblinded themselves.", "population_specificity": "Participants from the CANNA-TICS trial (54 out of 97) who were treated at the study center in Hannover.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:47.209675+00:00"}
{"study_id": 40674, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate THC concentrations in blood and saliva after oral administration of medical cannabis and determine the time needed for THC levels to decline below legal driving limits.", "results_summary": "THC was undetectable in saliva at all intervals after administration, but low levels were detected in blood in two subjects (one at 9 hours post lower dose, one at 7 hours post higher dose). The study suggested waiting at least 9-10 hours after cannabis use before driving.", "population_specificity": "20 patients with chronic pain on long-term medical cannabis therapy.", "effective_dosage": "62.5 mg or 125 mg THC in gelatin capsules.", "study_duration": "Single administration with follow-up measurements over several hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:48.555898+00:00"}
{"study_id": 40675, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether THC modulates extracellular vesicles (BG-EVs) and their miRNA cargo in the basal ganglia during SIV infection, and its potential role in HIV neuropathogenesis.", "results_summary": "THC treatment led to significant upregulation of 37 miRNAs in BG-EVs from SIV-infected macaques, many linked to inflammation, immune regulation, and cell signaling pathways. BG-EVs from THC-treated subjects altered astrocyte activation and gene expression in a CX3CR1-dependent manner.", "population_specificity": "Rhesus macaques infected with SIV and primary astrocytes from wild-type and CX3CR1+/GFP mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:49.429696+00:00"}
{"study_id": 40676, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of THC and CBD on macrophage activation and their potential therapeutic impact in a murine colitis model.", "results_summary": "THC inhibited macrophage nitric oxide and cytokine secretion, altered cell surface molecule expression, improved clinical scores in colitis, and reduced macrophage colon infiltration. Cannabis extracts showed higher activity than pure cannabinoids, with unique effects on cytokine composition.", "population_specificity": "Young and aged C57BL/6 mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:49.603547+00:00"}
{"study_id": 40662, "supplement_id": 1612, "safety_score": "40", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the cardio-respiratory and vascular effects of \u03949-THC in awake CD-1 male mice and compare them to synthetic cannabinoid JWH-018.", "results_summary": "\u03949-THC caused delayed bradycardia, minor tachyarrhythmias, bradypnea, and transient mild hypertension at tested doses. These effects were prevented by CB1 and CB2 receptor antagonists, suggesting involvement of both receptor types.", "population_specificity": "Awake CD-1 male mice", "effective_dosage": "0.3-3-6 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:49.986933+00:00"}
{"study_id": 40677, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effects of THC on NAFLD progression, including its impact on liver inflammation, glucose tolerance, and gut microbiota composition.", "results_summary": "THC showed a weak response, slightly reducing inflammatory-related gene expression and microbiome dysbiosis but did not alleviate hepatic steatosis or significantly improve other NAFLD-related parameters.", "population_specificity": "Mice fed a high fat-cholesterol diet (HFCD) to induce NAFLD.", "effective_dosage": "2.5 mg/kg added to the experimental diet.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:51.682896+00:00"}
{"study_id": 40679, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if \u03949-THC could protect against cardiovascular dysfunction caused by ischemia/reperfusion (I/R) injury in rat hearts and human cardiac myocytes.", "results_summary": "\u03949-THC improved cardiac function recovery, reduced cell damage, decreased ROS levels, enhanced antioxidant capacity, and increased CERK production in I/R-injured cells. It also inhibited harmful morphological changes and decreased cell death.", "population_specificity": "Isolated rat hearts and human cardiac myocytes (HCM) culture.", "effective_dosage": "10 \u03bcM \u03949-THC.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:53.737830+00:00"}
{"study_id": 40678, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of acute THC exposure on working memory and attention in adult male rats, comparing high-THC and low-THC Cannabis smoke to systemic THC injections.", "results_summary": "Acute high-THC smoke exposure and THC injections impaired working memory (TUNL task) but did not affect attention, impulsivity, or perseveration (5-CSRTT). Low-THC smoke exposure had no significant impact on working memory.", "population_specificity": "Adult male rats", "effective_dosage": "Systemic THC injection (3.0 mg/kg; i.p.), high-THC and low-THC Cannabis smoke (specific dosages not detailed)", "study_duration": "Acute exposure (single session)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:54.255123+00:00"}
{"study_id": 40680, "supplement_id": 1612, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of low-dose intranasal THC on memory decline and Alzheimer's disease-related biomarkers in a transgenic mouse model.", "results_summary": "Low-dose intranasal THC (0.002 and 0.02 mg/kg) slowed memory decline, reduced A\u03b2 peptides, decreased p-tau levels, and improved mitochondrial function markers in APP/PS1 mice, with minimal systemic effects.", "population_specificity": "12-month-old APP/PS1 transgenic mice (Alzheimer's disease model).", "effective_dosage": "0.002 and 0.02 mg/kg, administered daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:55.858430+00:00"}
{"study_id": 40681, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of THC on oocyte maturation and early embryonic development.", "results_summary": "THC at recreational doses (0.32 and 3.2 \u03bcM) significantly impaired oocyte maturation and cleavage rates, while therapeutic doses (0.032 \u03bcM) showed lower connexin mRNA levels. Blastocysts from higher THC doses exhibited increased apoptosis, but no differences in developmental rates or cell proportions were observed.", "population_specificity": "Bovine oocytes matured in vitro.", "effective_dosage": "0.032 \u03bcM (therapeutic), 0.32 \u03bcM, and 3.2 \u03bcM (recreational).", "study_duration": "24 hours (oocyte maturation).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:57.152495+00:00"}
{"study_id": 40683, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of chronic THC administration on platelet function using a nonhuman primate model.", "results_summary": "Chronic THC administration reduced platelet adhesion, aggregation, and granule secretion in response to select platelet agonists in both female and male NHPs. Additionally, changes in bioactive lipids (oxylipins) were observed in the female cohort after THC administration.", "population_specificity": "Nonhuman primates (NHPs), both female and male", "effective_dosage": "Daily THC edible (specific dosage not mentioned)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:57.443314+00:00"}
{"study_id": 40684, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adolescent THC exposure and maternal immune activation (MIA) synergistically worsen behavioral outcomes in adult mice.", "results_summary": "Adolescent THC treatment caused spatial memory deficits and enhanced spatial reversal learning in adult female mice, while MIA led to female-specific fear extinction learning deficits. No synergistic effects between THC and MIA were observed in either sex.", "population_specificity": "Adult mice (male and female) with prenatal MIA exposure and adolescent THC treatment.", "effective_dosage": "3 mg/kg/day THC for 5 days.", "study_duration": "5 days during adolescence.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:31:58.718649+00:00"}
{"study_id": 40685, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of adolescent THC exposure on synaptic plasticity and cognitive function in adulthood, with a focus on sex-specific differences.", "results_summary": "Adolescent THC exposure caused significant deficits in synaptic plasticity, particularly in female rats and mice, impairing long-term potentiation and memory functions. These effects were sexually dimorphic and varied by brain region, suggesting lasting cognitive impacts from early cannabinoid use.", "population_specificity": "Adolescent rats and mice (both sexes).", "effective_dosage": "Daily \u03949-tetrahydrocannabinol treatments (specific dosage not mentioned).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:00.294921+00:00"}
{"study_id": 40687, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether THC and CBD could inhibit \u03b2-haematin formation and malaria parasite growth, exploring their potential as antimalarial agents.", "results_summary": "THC inhibited \u03b2-haematin and malaria parasite growth, but its psychoactive effects were noted as undesirable. CBD also inhibited \u03b2-haematin but showed only mild antimalarial activity. The study suggests cannabinoids as a new chemical class for malaria treatment research.", "population_specificity": "Malaria parasites (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:02.022246+00:00"}
{"study_id": 40682, "supplement_id": 1612, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and tolerability of nabiximols (THC:CBD spray) versus oral dronabinol (synthetic THC) as add-on treatments for severe neuropathic pain in patients poorly responsive to standard therapies.", "results_summary": "Nabiximols showed superior effectiveness (55.4% improvement in symptom relief vs. 40.5% for dronabinol) and better tolerability (lower incidence of adverse events and discontinuations). The study concluded that combining CBD with THC is particularly beneficial for this patient population.", "population_specificity": "Adult outpatients with severe neuropathic pain poorly responsive to established treatments.", "effective_dosage": "Mean THC dose was 16.6 mg/day for nabiximols and 17.2 mg/day for dronabinol.", "study_duration": "24 weeks", "interactions": "Reduced use of non-cannabinoid pain medications, especially opioids, was noted with nabiximols.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:02.109981+00:00"}
{"study_id": 40686, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to understand patterns of delta-8-THC use, its perceived effectiveness compared to delta-9-THC and pharmaceutical drugs, and its role in treating health and medical conditions.", "results_summary": "Delta-8-THC was used primarily for anxiety, stress, depression, and chronic pain, with participants favoring it over delta-9-THC and pharmaceuticals. Most users did not inform their primary care providers, and knowledge of effective dosages was low.", "population_specificity": "Delta-8-THC consumers in the United States, primarily using edibles or vaping concentrates.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:02.951125+00:00"}
{"study_id": 40688, "supplement_id": 1612, "safety_score": "20", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the long-term effects of chronic adolescent THC administration on M1 and CB1 receptor distribution and function in the PL-PFC, and its impact on PFC-dependent memory.", "results_summary": "Chronic THC administration in adolescent mice reduced M1R gold particles in small dendrites, attenuated hyperpolarization, increased firing rates in response to muscarinic stimulation, and impaired PFC-dependent memory function in adulthood.", "population_specificity": "Adolescent male C57BL/6J mice", "effective_dosage": "Escalating daily doses (specific amounts not provided)", "study_duration": "Duration not explicitly stated (chronic administration during adolescence)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:04.365906+00:00"}
{"study_id": 40689, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of dronabinol (synthetic THC) as an adjunctive treatment for agitation in Alzheimer's dementia.", "results_summary": "The abstract provides baseline data for an ongoing study but does not report final results on THC's effects. Preliminary findings describe the enrolled participants' demographics and agitation levels.", "population_specificity": "80 participants (44 enrolled so far) with advanced cognitive impairment and agitation, predominantly female and white.", "effective_dosage": "10 mg daily (titrated)", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:05.074445+00:00"}
{"study_id": 40691, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether THC alone or in combination with CBD improves cognitive performance in aged mice, focusing on spatial learning.", "results_summary": "Low-dose THC (1 mg/kg/day) improved spatial learning in aged mice, but a 1:1 THC-CBD combination did not, likely due to CBD-induced transient changes in THC metabolism leading to rapid clearance. THC alone was more effective than the combination.", "population_specificity": "Aged mice", "effective_dosage": "1 mg/kg/day THC, 1:1 THC-CBD ratio", "study_duration": "Prolonged exposure (exact duration not specified)", "interactions": "CBD altered THC metabolism, causing transient elevation and rapid clearance of THC.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:06.616818+00:00"}
{"study_id": 40692, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the long-term effects of THC and CBD co-administration in adolescent female rats, focusing on behavioral and neurobiological outcomes.", "results_summary": "The study found that CBD mitigated some long-term behavioral and neurobiological effects of THC in adolescent rats, but a high CBD:THC ratio (33:1) led to adverse cognitive effects and anhedonia, with lasting changes in GABAergic neurotransmission.", "population_specificity": "Adolescent female rats", "effective_dosage": "THC and CBD at a 3:1 ratio; CBD:THC at a 33:1 ratio (total THC 0.3%)", "study_duration": "Chronic administration (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:08.121286+00:00"}
{"study_id": 40693, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to summarize controlled trials evaluating the effects of THC and CBD on symptoms, cognition, and brain function in individuals with schizophrenia.", "results_summary": "THC worsened psychosis and learning/recall in one trial but showed no symptom changes and improved brain function in another. CBD had mixed results, with some studies showing symptom improvement and others showing no effect.", "population_specificity": "Individuals with schizophrenia, including those with and without cannabis use disorder (CUD).", "effective_dosage": "Intravenous THC (specific dose not stated), smoked or oral THC (dose not specified), CBD (600 mg, 800 mg, and 1,000 mg).", "study_duration": "Ranged from single-dose administration to 6 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:09.973122+00:00"}
{"study_id": 40695, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the long-term behavioral and neurochemical effects of perinatal THC exposure in mice, particularly its interaction with fluoxetine and the endocannabinoid system.", "results_summary": "Perinatal THC exposure altered repetitive and hedonic behaviors in a sex-dependent manner and prevented fluoxetine from enhancing coping behavior in the forced swim test. FAAH inhibition restored fluoxetine responsiveness, suggesting lasting ECS disruption.", "population_specificity": "Pregnant CD1 mice and their offspring.", "effective_dosage": "3 mg/kg THC daily.", "study_duration": "From gestational day 5 to postnatal day 10.", "interactions": "Interaction with fluoxetine noted; FAAH inhibition restored fluoxetine efficacy.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:10.931141+00:00"}
{"study_id": 40696, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antioxidant activity of THC and other cannabinoids compared to vitamin E.", "results_summary": "The study found that THC exhibits antioxidant activity, including scavenging free radicals, preventing oxidation, and reducing metal ions, with efficacy comparable to vitamin E. The antioxidant effects varied based on the electron-accepting species (radicals/metal ions).", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:11.264451+00:00"}
{"study_id": 40694, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the acute effects of THC on adult zebrafish behavior and the underlying mechanisms, particularly its potential link to psychosis-like effects.", "results_summary": "THC induced concentration-dependent behavioral stereotypy in zebrafish, resembling effects seen in rats and other psychotropics. The study identified NMDA receptor antagonism and cannabinoid receptor 2 involvement as potential mechanisms, with antipsychotic sulpiride reducing THC-induced effects.", "population_specificity": "Adult zebrafish", "effective_dosage": "Not specified (concentration-dependent)", "study_duration": "Acute exposure (duration not specified)", "interactions": "NMDA receptor agonist NMDA, GABA receptor antagonist pentylenetetrazol, cannabinoid receptor 1 inverse agonist AM251, inverse cannabinoid receptor 2 agonist AM630, and antipsychotic sulpiride.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:11.613351+00:00"}
{"study_id": 40698, "supplement_id": 1612, "safety_score": "20", "efficacy_score": 10, "quality_score": 75, "study_goal": "The researchers sought to determine whether THC could restore wheel running depressed by IBD-like symptoms induced by TNBS in rats.", "results_summary": "THC administration prolonged TNBS-induced depression of wheel running in both adolescent and adult rats, exacerbating IBD symptoms instead of providing relief. No antinociceptive effect of THC was observed.", "population_specificity": "Adolescent and adult female Sprague-Dawley rats.", "effective_dosage": "0.32 mg/kg, subcutaneous injection.", "study_duration": "Effects monitored for over 5 days post-TNBS administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:13.372729+00:00"}
{"study_id": 40697, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of gabapentin in attenuating THC withdrawal symptoms in mice.", "results_summary": "Gabapentin reduced somatic signs of THC withdrawal (e.g., paw tremors, head twitches) and restored withdrawal-suppressed behaviors in some tests but had no effect on locomotor activity, conditioned place preference, or stress response markers like corticosterone.", "population_specificity": "Male and female mice", "effective_dosage": "THC (10 mg/kg, s.c. for 5.5 days); gabapentin (\u226510 mg/kg to 50 mg/kg)", "study_duration": "5.5 days of THC administration, withdrawal precipitated on the sixth day", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:13.754354+00:00"}
{"study_id": 40699, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the mechanism by which THC interacts with amyloid-\u03b2 protofibrils and its potential to disrupt these fibrils in Alzheimer's disease.", "results_summary": "THC molecules disrupted amyloid-\u03b2 protofibril structure by binding strongly to them, primarily through hydrophobic interactions. This led to loosening of the protofibril core, disruption of stabilizing salt bridges and hydrogen bonds, and a reduction in \u03b2-sheet content.", "population_specificity": "Not specified (in vitro molecular dynamics simulation study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:14.555018+00:00"}
{"study_id": 40700, "supplement_id": 1612, "safety_score": "30", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine the long-term effects of daily high-dose THC consumption in adolescent primates and whether CBD modulates these effects.", "results_summary": "THC initially impaired cognitive performance and reduced motor activity, with tolerance developing after weeks. CBD did not modulate THC's cognitive or activity effects but prevented THC-induced emesis on the first day.", "population_specificity": "Adolescent squirrel monkeys (Saimiri boliviensis)", "effective_dosage": "1 mg/kg THC (i.m., daily), 3 mg/kg CBD (i.m., daily)", "study_duration": "Four months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:16.471303+00:00"}
{"study_id": 40701, "supplement_id": 1612, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to characterize the acute effects of \u03949-THC on driving performance and driving-related cognitive skills, focusing on the duration of impairment.", "results_summary": "The study found that \u03949-THC impairs driving performance and cognitive skills, with regular users experiencing less impairment than occasional users. Most impairment from inhaled THC (20 mg) subsides within ~5 hours, while oral THC-induced impairment may take longer.", "population_specificity": "Regular and occasional cannabis users.", "effective_dosage": "20 mg inhaled \u03949-THC (mentioned for recovery analysis).", "study_duration": "Not specified (acute effects assessed).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:18.671206+00:00"}
{"study_id": 40703, "supplement_id": 1612, "safety_score": "65", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of THC, particularly in combination with CBD, for treating symptoms of multiple sclerosis, such as spasticity and neuropathic pain.", "results_summary": "The study found that THC, especially in combination with CBD, was moderately effective in reducing spasticity scores in humans, though less effective than in animal models. It also noted potential cognitive dysfunction as a side effect.", "population_specificity": "People with multiple sclerosis (pwMS)", "effective_dosage": "1:1 ratio of THC to CBD (specific dosage not mentioned)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:19.800440+00:00"}
{"study_id": 40702, "supplement_id": 1612, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "To determine the benefit of THC-rich cannabis oil on symptoms and quality of life in fibromyalgia patients.", "results_summary": "The cannabis group showed significant improvement in Fibromyalgia Impact Questionnaire scores, particularly in \"feel good,\" \"pain,\" \"do work,\" and \"fatigue\" items, compared to placebo. No intolerable adverse effects were reported.", "population_specificity": "17 women with fibromyalgia from a low socioeconomic, high-violence neighborhood in Florianopolis, Brazil.", "effective_dosage": "Initial dose of ~1.22 mg THC and 0.02 mg CBD per day, with subsequent increases as needed.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:20.826085+00:00"}
{"study_id": 99404, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers were examining the potential role of Vitamin A metabolism in the pathophysiology of idiopathic intracranial hypertension.", "results_summary": "The abstract does not provide specific findings about Vitamin A's effects, only mentioning it as an area of active study in relation to the disease.", "population_specificity": "Young obese women with idiopathic intracranial hypertension.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:27.312048+00:00"}
{"study_id": 99401, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review hereditary transthyretin (TTR) amyloidosis, focusing on TTR's role as a transport protein for thyroid hormones and vitamin A, and its disease mechanisms.", "results_summary": "The abstract discusses TTR's biology, amyloid fibril formation, and disease models but does not report specific findings on Vitamin A's effects.", "population_specificity": "Individuals with hereditary transthyretin (TTR) amyloidosis.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:28.319355+00:00"}
{"study_id": 99397, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers were examining the role of Vitamin A metabolism dysfunction in the etiology and treatment of pityriasis rubra pilaris (PRP).", "results_summary": "The abstract suggests Vitamin A is part of empirical systemic treatment for PRP, but efficacy is not clearly demonstrated, and newer biologicals like TNF-\u03b1 blockers are noted as potentially safer and more effective.", "population_specificity": "Patients with pityriasis rubra pilaris (PRP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:28.454897+00:00"}
{"study_id": 99403, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the mechanisms of all-trans-retinal clearance in photoreceptor cells and its role in retinal photodamage, including potential links to degenerative diseases like Stargardt's disease and age-related macular degeneration.", "results_summary": "The study found that accumulation of all-trans-retinal can lead to retinal photodamage and degenerative diseases, highlighting the importance of enzymatic clearance pathways and reviewing potential therapeutic strategies to prevent such damage.", "population_specificity": "Not specified (focus on photoreceptor cells and retinal degenerative diseases in general)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:29.040101+00:00"}
{"study_id": 99398, "supplement_id": 1659, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the chemopreventive potential of Fenretinide (a Vitamin A derivative) in reducing breast cancer incidence, particularly in high-risk populations.", "results_summary": "Fenretinide significantly reduced the incidence of second breast tumors in premenopausal women, with effects confirmed after 15-year follow-ups. It also showed a protective trend against ovarian cancer, suggesting its potential as a preventive agent for high-risk young women.", "population_specificity": "Premenopausal women, particularly those with BRCA-1 and 2 mutations or high familial risk.", "effective_dosage": "Not specified", "study_duration": "15-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:29.140869+00:00"}
{"study_id": 99399, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effectiveness of community-based marketing and distribution of Sprinkles MNP (containing vitamin A) in reducing childhood anemia and vitamin A deficiency in a resource-poor setting.", "results_summary": "The study found that Sprinkles MNP significantly improved vitamin A deficiency (7.5% decrease in intervention vs. 2.5% increase in control) and hemoglobin levels, with efficacy linked to the number of sachets consumed. No significant changes in malaria, wasting, or stunting were observed.", "population_specificity": "Children aged 6-35 months in Western Kenya.", "effective_dosage": "~328 \u03bcg vitamin A per sachet, average weekly intake of 0.9 sachets per child.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:30.275804+00:00"}
{"study_id": 99402, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether rice fortified with multiple micronutrients, including Vitamin A, could improve micronutrient status, anemia prevalence, and physical/cognitive performance in school children.", "results_summary": "The study found that <10% of children were deficient in Vitamin A at baseline, and no significant changes in Vitamin A status were observed after the intervention. The fortified rice improved vitamin B-12 status and physical performance but did not notably affect Vitamin A levels.", "population_specificity": "6- to 12-year-old, low-income school children in Bangalore, India.", "effective_dosage": "Not specified for Vitamin A (only iron concentrations: 6.25 mg or 12.5 mg).", "study_duration": "6 months (6 days/week).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:30.329743+00:00"}
{"study_id": 99400, "supplement_id": 1659, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of a single high-dose (200,000 IU) versus daily low-dose (5,000 IU) Vitamin A in managing children with severe acute malnutrition (SAM) accompanied by diarrhea and/or acute lower respiratory tract infection (ALRI).", "results_summary": "The study found no significant difference in outcomes (resolution of diarrhea, ALRI, edema, anthropometric changes, or biochemical indicators) between the high-dose and low-dose Vitamin A groups. High-dose Vitamin A showed no adverse events.", "population_specificity": "Children aged 6-59 months with severe acute malnutrition (weight-for-height <-3 Z-score and/or bipedal edema), all with diarrhea and 54% with concomitant ALRI.", "effective_dosage": "Single high-dose (200,000 IU) on admission day plus daily low-dose (5,000 IU) for 15 days.", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:31.033333+00:00"}
{"study_id": 99405, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential role of Vitamin A derivatives (retinoids) in influencing Alzheimer's disease pathogenesis, particularly their effects on Amyloid beta processing and fibril formation.", "results_summary": "Retinoids may upregulate alpha secretase via ADAM10 and directly inhibit Amyloid fibril formation, suggesting potential relevance to Alzheimer's disease. Clinical studies in cognitively impaired older adults are underway to assess efficacy and safety.", "population_specificity": "Cognitively impaired older adults with Alzheimer's disease (studies mentioned but not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:35.799243+00:00"}
{"study_id": 99407, "supplement_id": 1659, "safety_score": "30", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to assess the beneficial and harmful effects of antioxidant supplements, including Vitamin A, on mortality in adults.", "results_summary": "The study found that Vitamin A did not significantly affect mortality overall, but higher doses were associated with increased mortality in univariate meta-regression analysis. The effect was not statistically significant in the primary analysis.", "population_specificity": "Adults (mean age 63 years, range 18-103), including healthy participants and those with various stable diseases (46% women).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Mean duration of 3 years (range 28 days to 12 years).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:37.152281+00:00"}
{"study_id": 99406, "supplement_id": 1659, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess whether micronutrient supplements, including Vitamin A, are effective and safe in reducing mortality and morbidity in HIV-infected pregnant and lactating women and their infants.", "results_summary": "The study found that multiple micronutrient supplements, including Vitamin A, conferred clinical benefits to pregnant women and their offspring without significant adverse effects. However, no direct comparisons or analyses were made across trials, and the evidence for Vitamin A alone was not isolated.", "population_specificity": "HIV-infected pregnant and lactating women in Tanzania, recruited from urban hospital-based antenatal clinics with gestational ages ranging from 12 to 27 weeks.", "effective_dosage": "Not specified", "study_duration": "Duration of pregnancy and at least 6 weeks postpartum", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:37.406471+00:00"}
{"study_id": 99408, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of postpartum maternal supplementation with 400,000 IU versus 200,000 IU of vitamin A on infant morbidity.", "results_summary": "The study found no significant differences in infant morbidity (fever, diarrhea, otitis, acute respiratory infection, need for intravenous rehydration, or antibiotic use) between the two vitamin A dosage groups, suggesting that doubling the dose did not provide additional benefits.", "population_specificity": "Postpartum mothers and their infants in northeastern Brazil.", "effective_dosage": "400,000 IU or 200,000 IU of vitamin A (single dose).", "study_duration": "Follow-up for >6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:37.625292+00:00"}
{"study_id": 99410, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the impact of vitamin A alone or combined with other micronutrients on anemia and growth in preschoolers.", "results_summary": "Vitamin A combined with zinc improved height and height-for-age z-scores, while vitamin A with multiple micronutrients increased weight and hemoglobin concentrations. All three supplement types reduced anemia prevalence and enhanced growth.", "population_specificity": "Preschoolers aged 36-72 months (n=290).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:37.948987+00:00"}
{"study_id": 99409, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether postpartum supplementation with retinyl palmitate increases secretory immunoglobulin A (SIgA) levels in colostrum.", "results_summary": "The study found that supplementation with retinyl palmitate significantly increased SIgA levels in colostrum compared to the unsupplemented group (501.2\u00b154.5 mg/dL vs. 343.9\u00b1177.2 mg/dL, p < 0.00001), suggesting vitamin A modulates antibody production.", "population_specificity": "96 recently-delivered mothers at a public maternity hospital.", "effective_dosage": "Not specified", "study_duration": "Supplementation occurred on the first day postpartum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:38.481459+00:00"}
{"study_id": 99412, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the extent of ocular morbidity in rural populations and identify associated factors, including the role of Vitamin A prophylaxis in reducing xerophthalmia.", "results_summary": "The study found that xerophthalmia accounted for 10.20% of ocular morbidity cases, suggesting Vitamin A prophylaxis could help reduce this burden. No specific efficacy data on Vitamin A supplementation were provided, but it was recommended as a targeted intervention.", "population_specificity": "Rural populations in Jasra and Saidabad blocks of Allahabad District, India, including subgroups like the elderly, females, illiterates, and low socioeconomic strata.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:39.968526+00:00"}
{"study_id": 99411, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine if neonatal vitamin A supplementation (50,000 IU) given within two days of birth reduces mortality from supplementation to 6 months of age compared to placebo.", "results_summary": "The abstract does not report results, as the studies are ongoing. The trials are designed to assess mortality outcomes at 6 and 12 months.", "population_specificity": "Neonates in Ghana, India, and Tanzania meeting eligibility criteria (age, residency, oral feeding ability, and parental consent).", "effective_dosage": "50,000 IU, single oral dose at enrollment.", "study_duration": "Single dose administered within two days of birth.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:40.576330+00:00"}
{"study_id": 99413, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To determine if a diet high in \u03c9-3 fatty acids could slow visual acuity loss in retinitis pigmentosa patients taking vitamin A palmitate.", "results_summary": "High \u03c9-3 intake (\u22650.20 g/d) was associated with slower declines in visual acuity compared to low intake (<0.20 g/d) over 4-6 years. The effect was statistically significant for both distance and retinal acuity measures.", "population_specificity": "357 adult patients with retinitis pigmentosa from 3 randomized trials.", "effective_dosage": "15,000 IU/d of vitamin A palmitate.", "study_duration": "4 to 6 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:44.417202+00:00"}
{"study_id": 99414, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the integration of Vitamin A supplementation with immunization programs as part of maternal and child health services.", "results_summary": "The study found that integrating Vitamin A supplementation with immunization programs increased coverage of the linked intervention, though not always to the level of immunization coverage. Challenges included logistical difficulties and low immunization coverage.", "population_specificity": "Maternal and child health service recipients, likely including infants and young children.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:44.612545+00:00"}
{"study_id": 99415, "supplement_id": 1659, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize the effects of Vitamin A status and retinoid treatments on metabolism in various tissues and propose a mechanism for its role in glucose and lipid homeostasis.", "results_summary": "The study found that Vitamin A and retinoids impact energy metabolism in liver, adipocytes, pancreatic \u03b2-cells, and skeletal muscle, suggesting a role in glucose and lipid homeostasis through the activation of nuclear receptors like RXR. It also proposed a mechanism involving the sterol regulatory element-binding protein 1c gene to induce lipogenic gene expression in hepatocytes.", "population_specificity": "Animals and humans (basic and clinical investigations)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:32:46.098186+00:00"}
